ARCHIVED — COMMISSIONS

Warning This Web page has been archived on the Web.

Archived Content

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Vol. 142, No. 27 — July 5, 2008

CANADA REVENUE AGENCY

INCOME TAX ACT

Revocation of registration of a charity

The following notice of proposed revocation was sent to the charity listed below revoking it for failure to meet the parts of the Income Tax Act as listed in this notice:

“Notice is hereby given, pursuant to paragraphs 168(1)(b), 168(1)(d) and 168(1)(e) of the Income Tax Act, that I propose to revoke the registration of the organization listed below under subsection 149.1(2) of the Income Tax Act and that the revocation of the registration is effective on the date of publication of this notice.”

Business Number

Name/Address

895468981RR0001

HOLY ALPHA AND OMEGA CHURCH OF TORONTO, ETOBICOKE, ONT.

TERRY DE MARCH
Director General
Charities Directorate

[27-1-o]

CANADA REVENUE AGENCY

INCOME TAX ACT

Revocation of registration of a charity

The following notice of proposed revocation was sent to the charity listed below revoking it for failure to meet the parts of the Income Tax Act as listed in this notice:

“Notice is hereby given, pursuant to paragraphs 168(1)(b), 168(1)(d) and 168(1)(e) of the Income Tax Act, that I propose to revoke the registration of the organization listed below under subsections 149.1(2) and 149.1(4.1) of the Income Tax Act and that the revocation of the registration is effective on the date of publication of this notice.”

Business Number

Name/Address

871949806RR0001

WORLD COUNCIL FOR AFRICAN DEVELOPMENT, ETOBICOKE, ONT.

TERRY DE MARCH
Director General
Charities Directorate

[27-1-o]

CANADIAN RADIO-TELEVISION AND TELECOMMUNICATIONS COMMISSION

NOTICE TO INTERESTED PARTIES

The following notices are abridged versions of the Commission’s original notices bearing the same number. The original notices contain a more detailed outline of the applications, including additional locations and addresses where the complete files may be examined. The relevant material, including the notices and applications, is available for viewing during normal business hours at the following offices of the Commission:

— Central Building, Les Terrasses de la Chaudière, Room 206, 1 Promenade du Portage, Gatineau, Quebec K1A 0N2, 819-997-2429 (telephone), 994-0423 (TDD), 819-994-0218 (fax);

— Metropolitan Place, Suite 1410, 99 Wyse Road, Dartmouth, Nova Scotia B3A 4S5, 902-426-7997 (telephone), 426-6997 (TDD), 902-426-2721 (fax);

— Kensington Building, Suite 1810, 275 Portage Avenue, Winnipeg, Manitoba R3B 2B3, 204-983-6306 (telephone), 983-8274 (TDD), 204-983-6317 (fax);

— 530–580 Hornby Street, Vancouver, British Columbia V6C 3B6, 604-666-2111 (telephone), 666-0778 (TDD), 604-666-8322 (fax);

— CRTC Documentation Centre, 205 Viger Avenue W, Suite 504, Montréal, Quebec H2Z 1G2, 514-283-6607 (telephone), 283-8316 (TDD), 514-283-3689 (fax);

— CRTC Documentation Centre, 55 St. Clair Avenue E, Suite 624, Toronto, Ontario M4T 1M2, 416-952-9096 (telephone), 416-954-6343 (fax);

— CRTC Documentation Centre, Cornwall Professional Building, Room 103, 2125 11th Avenue, Regina, Saskatchewan S4P 3X3, 306-780-3422 (telephone), 306-780-3319 (fax);

— CRTC Documentation Centre, 10405 Jasper Avenue, Suite 520, Edmonton, Alberta T5J 3N4, 780-495-3224 (telephone), 780-495-3214 (fax).

Interventions must be filed with the Secretary General, Canadian Radio-television and Telecommunications Commission, Ottawa, Ontario K1A 0N2, together with proof that a true copy of the intervention has been served upon the applicant, on or before the deadline given in the notice.

Secretary General

CANADIAN RADIO-TELEVISION AND TELECOMMUNICATIONS COMMISSION

DECISIONS

The complete texts of the decisions summarized below are available from the offices of the CRTC.

2008-127 June 26, 2008

Canadian Broadcasting Corporation
Sackville, New Brunswick

Approved — Amendment to the broadcasting licence for the radio station CKCX Sackville in order to add the frequencies 7 310 kHz, 7 325 kHz and 7 345 kHz for its short-wave operation.

2008-128 June 26, 2008

9183-9084 Québec inc.
Québec, Quebec

Approved — Acquisition, from 591991 B.C. Ltd., of the assets of the French-language commercial AM radio programming undertaking CHRC Québec and issuance of a broadcasting licence to continue the operation of the undertaking.

2008-129 June 26, 2008

TQS inc.
Montréal, Québec, Trois-Rivières, Sherbrooke and Saguenay, Quebec

Approved — Change of the effective control of TQS inc. (TQS), licensee of the television programming undertakings CFJP-TV Montréal, CFJP-DT Montréal, CFAP-TV Québec, CFKM-TV Trois-Rivières, CFKS-TV Sherbrooke and CFRS-TV Saguenay, and of the TQS network, through the transfer of all of the issued and outstanding shares of 3947424 Canada Inc., the parent corporation of TQS, currently held by Cogeco Radio-Télévision inc. (60%) and CTV Television Inc. (40%), to Remstar Diffusion inc., a corporation owned and controlled by Julien and Maxime Rémillard.

Approved — Renewal of the broadcasting licences for the above-mentioned stations from September 1, 2008, to August 31, 2015. The licences will be subject to the conditions set out in the appendices to this decision.

2008-130 June 26, 2008

Canadian Broadcasting Corporation
Sherbrooke, Trois-Rivières, Saguenay and Saint-Fulgence, Quebec

Approved — Acquisition of the assets of the French-language television programming undertakings CKSH-TV Sherbrooke, CKTM-TV Trois-Rivières and CKTV-TV Saguenay and its transmitter CKTV-TV-1 Saint-Fulgence, Quebec, from TQS inc, and issuance of new broadcasting licences to continue the operation of the undertakings.

[27-1-o]

HAZARDOUS MATERIALS INFORMATION REVIEW COMMISSION

HAZARDOUS MATERIALS INFORMATION REVIEW ACT

Decisions and orders on claims for exemption

Pursuant to paragraph 18(1)(a) of the Hazardous Materials Information Review Act, the Chief Screening Officer of the Hazardous Materials Information Review Commission hereby gives notice of the decisions of the screening officer, respecting each claim for exemption and the relevant material safety data sheet (MSDS) and (where applicable) the label, listed below.

Claimant

Product Identifier
(As shown on the MSDS)

Registry Number

MSDS
Preparation
Date
(As shown
on the MSDS)

Date of Decision

Milacron Marketing Co., Cincinnati, Ohio

CIMPERIAL® 1080CFZ

6082

8/31/2006

May 9, 2008

         

Chemtrade Logistics Inc., North York, Ontario

VIRWITE LIQUID (SERIES 100) formerly
Sodium Hydrosulfite Solution

6183

8-1-2007

February 8, 2008

         

Cytec Industries Inc.,
West Paterson,
New Jersey

CYCOM® 5208GD Structural Prepreg

6221

07/08/2005

May 1, 2008

         

Cytec Industries Inc.,
West Paterson,
New Jersey

FM® 94 Adhesive Film

6222

07/08/2005

May 1, 2008

         

Cytec Industries Inc.,
West Paterson,
New Jersey

FM® 300-1 Adhesive Film

6223

02/16/2007

May 1, 2008

         

Cytec Industries Inc.,
West Paterson,
New Jersey

CYCOM® 985 Prepreg

6224

07/08/2005

January 25, 2008

         

Cytec Industries Inc.,
West Paterson,
New Jersey

HYE E773FR/Glass Prepreg

6225

07/08/2005

January 25, 2008

         

Cytec Industries Inc.,
West Paterson,
New Jersey

MXB 9032/Glass Prepreg

6226

07/08/2005

January 25, 2008

         

Cytec Industries Inc.,
West Paterson,
New Jersey

FX 986/Carbon Filament Prepreg

6227

07/08/2005

January 25, 2008

         

Cytec Industries Inc.,
West Paterson,
New Jersey

SURFACE MASTER® 905

6228

07/08/2005

January 25, 2008

         

Cytec Industries Inc.,
West Paterson,
New Jersey

CYCOM® 114/Glass Prepreg

6230

07/08/2005

January 25, 2008

         

Nexco Inc.,
North Bay, Ontario

NSOL 1000

6231

June 24, 2005

February 12, 2008

         

3M Canada Company, London, Ontario

3M(TM) PIEZO INK JET INK 1595 BLACK

6235

2007/04/09

February 8, 2008

         

Chemtrade Logistics Inc., North York, Ontario

VIRWITE POWDER (SERIES 100)

6238

8-1-2007

January 29, 2008

         

Hercules Canada Inc., Mississauga, Ontario

PROSOFT® TQ1003 SOFTENER formerly
Prosoft TQ1003

6246

15-AUG-2005

February 12, 2008

         

Hach Company, Ames, Iowa

DPD Free Chlorine Reagent

6249

10/16/07

January 31, 2008

         

Hach Company, Ames, Iowa

DPD Total Chlorine Reagent

6250

10/16/07

January 31, 2008

         

Hach Company, Ames, Iowa

DPD Compound for Free and Total Chlorine Analyzers

6251

10/16/07

January 31, 2008

         

Lubrizol Corporation, formerly
The Lubrizol Corporation, Wickliffe, Ohio

LUBRIZOL® 5706

6261

11 December 2007

April 18, 2008

         

Hexion Specialty Chemicals Canada Inc., Oshawa, Ontario

Fentak™ MR0950 formerly
Fentak MR 0950

6274

08-DEC-2006

January 30, 2008

         

Hexion Specialty Chemicals Canada Inc., Oshawa, Ontario

Fentak™ UR0269

6277

08-DEC-2006

January 30, 2008

         

Lubrizol Corporation, Wickliffe, Ohio

LUBRIZOL® 9690

6283

05 April 2007

April 18, 2008

         

Akzo Nobel Surface Chemistry LLC, Chicago, Illinois

C-5777

6287

9/7/2006

January 31, 2008

         

Akzo Nobel Surface Chemistry LLC, Chicago, Illinois

SPONTO® 300-T

6290

5/17/2007

March 31, 2008

         

Akzo Nobel Surface Chemistry LLC, Chicago, Illinois

SPONTO® 500-T

6292

5/17/2007

March 31, 2008

         

Akzo Nobel Surface Chemistry LLC, Chicago, Illinois

SPONTO® AD-11-1A

6293

1/20/2006

January 31, 2008

         

Akzo Nobel Surface Chemistry LLC, Chicago, Illinois

SPONTO® 727

6294

5/17/2007

March 31, 2008

         

Akzo Nobel Surface Chemistry LLC, Chicago, Illinois

SPONTO® N-141B

6295

1/20/2006

March 31, 2008

         

Akzo Nobel Surface Chemistry LLC, Chicago, Illinois

SPONTO® N-500B

6296

1/20/2006

February 27, 2008

         

Akzo Nobel Surface Chemistry LLC, Chicago, Illinois

SPONTO® B723

6297

1/20/2006

February 27, 2008

         

Akzo Nobel Surface Chemistry LLC, Chicago, Illinois

SPONTO® AM-1-23 C

6298

1/20/2006

February 27, 2008

         

Akzo Nobel Surface Chemistry LLC, Chicago, Illinois

SPONTO® AM-1-23 D

6299

1/20/2006

February 27, 2008

         

Akzo Nobel Surface Chemistry LLC, Chicago, Illinois

SPONTO® EC-300

6300

1/20/2006

February 27, 2008

         

Akzo Nobel Surface Chemistry LLC, Chicago, Illinois

ARMOHIB® PC-105

6302

8/16/2007

January 31, 2008

         

Akzo Nobel Surface Chemistry LLC, Chicago, Illinois

WITBREAK® 770

6303

5/17/2007

March 27, 2008

         

Akzo Nobel Surface Chemistry LLC, Chicago, Illinois

WITBREAK® DRM-9510

6304

1/20/2006

March 27, 2008

         

Akzo Nobel Surface Chemistry LLC, Chicago, Illinois

WITCOMUL™ 3158

6305

11/08/2005

February 27, 2008

         

Arkema Canada Inc.,
Oakville, Ontario

THERMOLITE® 176

6317

11/25/05

April 28, 2008

         

Arkema Canada Inc.,
Oakville, Ontario

PA-1121

6318

11/29/05

April 28, 2008

         

BYK USA Inc., formerly
BYK-Chemie USA, Inc.,
Wallingford, Connecticut

BYK-9077

6410

12/14/2005

March 31, 2008

         

Shell Canada Limited,
Calgary, Alberta

FORMAD05A

6411

2005-12-20

March 13, 2008

         

Cansolv Technologies Inc.,
Montréal, Québec

CANSOLV® DC 101 Solvent/
SOLVANT CANSOLV® DC-101

6412

2007-7-3

January 15, 2008

         

BYK USA Inc., formerly
BYK-Chemie USA, Inc.,
Wallingford, Connecticut

BYK-W 969 formerly
BYK®-W-969

6418

12/07/2006

April 10, 2008

         

3M Canada Company, London, Ontario

SCOTCH-WELD (TM) EPOXY ADHESIVE DP-190, TRANSLUCENT (PART A)

6425

2007/06/18

March 20, 2008

         

Enthone, Inc., West Haven, Connecticut

ENPREP® 126

6437

8/10/2007

January 18, 2008

         

Enthone, Inc., West Haven, Connecticut

ENPREP® 142

6438

4/26/2007

February 6, 2008

         

Nalco Canada Co.,
Burlington, Ontario

EC9008G

6468

2006/02/03

February 21, 2008

         

Cytec Industries Inc.,
West Paterson, New Jersey

CYCOM® 919HF Structural Resin

6469

02/03/2006

March 27, 2008

         

Cytec Industries Inc.,
West Paterson, New Jersey

FM® 87-1 HT Adhesive Film

6470

11/09/2007

March 27, 2008

         

Cytec Industries Inc.,
West Paterson, New Jersey

CYCOM® 919LB Structural Prepreg

6471

02/03/2006

March 27, 2008

         

Innovative Chemical Technologies Canada Ltd., Calgary, Alberta

Bwet

6476

July 17, 2006

February 19, 2008

         

Innovative Chemical Technologies Canada Ltd., Calgary, Alberta

DO 110

6477

August 14, 2006

March 14, 2008

         

Innovative Chemical Technologies Canada Ltd., Calgary, Alberta

DO 136

6478

August 14, 2006

March 14, 2008

         

Schlumberger Canada Limited, Calgary, Alberta

Non-Emulsifying Agent W54 formerly
Non-Emulsifying Agent W054

6487

22 October 2007

April 22, 2008

         

3M Canada Company, London, Ontario

3M (TM) SCOTCH-WELD (TM) STRUCTURAL PLASTIC ADHESIVE 8100, (PART B) formerly
3M (TM) Scotch-Weld (TM) Structural Adhesive 8100, (Part B)

6488

2007/11/02

March 20, 2008

         

BYK USA Inc., formerly
BYK-Chemie USA, Inc.,
Wallingford, Connecticut

BYK-S-740

6491

02/23/2006

January 31, 2008

         

BYK USA Inc., formerly
BYK-Chemie USA, Inc.,
Wallingford, Connecticut

BYK-085

6492

02/23/2006

January 31, 2008

         

BYK USA Inc., formerly
BYK-Chemie USA, Inc.,
Wallingford, Connecticut

BYK-3105

6493

02/23/2006

January 31, 2008

         

BYK USA Inc., formerly
BYK-Chemie USA, Inc.,
Wallingford, Connecticut

Anti-Terra-207

6495

04/20/2007

April 3, 2008

         

3M Canada Company, London, Ontario

3M (TM) SCREEN PRINTING UV INK SERIES 9800 PROCESS BASE

6497

2007-06-27

April 22, 2008

         

3M Canada Company, London, Ontario

3M (TM) SCREEN PRINTING UV INK 9802 OPAQUE BLACK formerly
3M (TM) SCREEN PRINTING UV INK SERIES 9802 OPAQUE BLACK

6498

2007-06-26

April 22, 2008

         

3M Canada Company, London, Ontario

3M (TM) SCREEN PRINTING UV INK 9803 MIXING BLACK formerly
3M (TM) SCREEN PRINTING UV INK SERIES 9803 MIXING BLACK

6499

2007-06-26

April 22, 2008

         

3M Canada Company, London, Ontario

9805P Process Black formerly
3M (TM) SCREEN PRINTING UV INK SERIES 9805P PROCESS BLACK

6500

2007-07-12

March 13, 2008

         

3M Canada Company, London, Ontario

3M (TM) SCREEN PRINTING UV INK 9806 MIXING WHITE

6501

2007-06-25

March 3, 2008

         

3M Canada Company, London, Ontario

3M (TM) SCREEN PRINTING UV INK 9808 OPAQUE WHITE

6502

2007-06-25

March 3, 2008

         

3M Canada Company, London, Ontario

3M (TM) SCREEN PRINTING UV INK 9810 UV TONER

6503

2007/06/25

March 31, 2008

         

3M Canada Company, London, Ontario

3M (TM) SCREEN PRINTING UV INK 9812 MAGENTA

6504

2007/06/25

March 31, 2008

         

3M Canada Company, London, Ontario

3M (TM) SCREEN PRINTING UV INK 9813 RED VIOLET

6505

2007/06/25

March 31, 2008

         

3M Canada Company, London, Ontario

9815 Process Magenta formerly
3M (TM) SCREEN PRINTING UV INK SERIES 9815 PROCESS MAGENTA

6506

2007-07-12

March 13, 2008

         

3M Canada Company, London, Ontario

3M (TM) SCREEN PRINTING UV INK SERIES 9825 TRANSPARENT RED (BS)

6507

2007-06-26

March 13, 2008

         

3M Canada Company, London, Ontario

3M (TM) SCREEN PRINTING UV INK SERIES 9826 BRICK RED

6508

2007-06-26

March 13, 2008

         

3M Canada Company, London, Ontario

3M (TM) SCREEN PRINTING UV INK SERIES 9827 RED

6509

2007/06/26

March 31, 2008

         

3M Canada Company, London, Ontario

3M (TM) SCREEN PRINTING UV INK SERIES 9828 TRANSPARENT RED (YS)

6510

2007/06/26

March 31, 2008

         

3M Canada Company, London, Ontario

3M (TM) SCREEN PRINTING UV INK SERIES 9830 ORANGE

6511

2007-06-26

March 28, 2008

         

3M Canada Company, London, Ontario

3M (TM) SCREEN PRINTING UV INK SERIES 9831 TRANSPARENT ORANGE

6512

2007-06-26

March 28, 2008

         

3M Canada Company, London, Ontario

3M (TM) SCREEN PRINTING UV INK SERIES 9837 RED SHADE YELLOW

6513

2007-06-26

March 28, 2008

         

3M Canada Company, London, Ontario

3M (TM) SCREEN PRINTING UV INK SERIES 9840 TRANSPARENT MEDIUM YELLOW

6514

2007-06-26

March 28, 2008

         

3M Canada Company, London, Ontario

3M (TM) SCREEN PRINTING UV INK SERIES 9843 MEDIUM YELLOW

6515

2007-06-26

March 28, 2008

         

3M Canada Company, London, Ontario

9845 PROCESS YELLOW formerly
3M (TM) SCREEN PRINTING UV INK SERIES 9845P PROCESS YELLOW

6516

2007-07-12

March 28, 2008

         

3M Canada Company, London, Ontario

3M (TM) SCREEN PRINTING UV INK SERIES 9848 TRANSPARENT YELLOW

6517

2007-06-27

March 28, 2008

         

3M Canada Company, London, Ontario

3M (TM) SCREEN PRINTING UV INK SERIES 9849 LEMON YELLOW

6518

2007-07-04

March 28, 2008

         

3M Canada Company, London, Ontario

3M (TM) SCREEN PRINTING UV INK SERIES 9861 LIGHT GREEN

6519

2007-06-27

March 28, 2008

         

3M Canada Company, London, Ontario

3M (TM) SCREEN PRINTING UV INK SERIES 9864 TRANSPARENT GREEN(BS)

6520

2007-06-27

March 28, 2008

         

3M Canada Company, London, Ontario

9875 PROCESS CYAN formerly
3M (TM) SCREEN PRINTING UV INK SERIES 9875P PROCESS CYAN

6521

2007-07-13

March 28, 2008

         

3M Canada Company, London, Ontario

3M (TM) SCREEN PRINTING UV INK SERIES 9879 BLUE (GS)

6522

2007-06-27

March 28, 2008

         

3M Canada Company, London, Ontario

3M (TM) SCREEN PRINTING UV INK SERIES 9882 TRANSPARENT BLUE

6523

2007-06-27

March 28, 2008

         

3M Canada Company, London, Ontario

3M (TM) SCREEN PRINTING UV INK SERIES 9891 BLUE VIOLET

6524

2007-06-27

March 28, 2008

         

Canyon Technical Services, Calgary, Alberta

CAN-1000

6534

1/9/2008

March 19, 2008

         

Canyon Technical Services, Calgary, Alberta

CAN-1100

6538

1/10/2008

March 19, 2008

         

Canyon Technical Services, Calgary, Alberta

Res-Clean S

6539

1/10/2008

February 22, 2008

         

Canyon Technical Services, Calgary, Alberta

Res-Clean PA

6540

1/10/2008

February 28, 2008

         

Lubrizol Corporation, Wickliffe, Ohio

LUBRIZOL® 5708

6542

26 November 2006

March 28, 2008

         

Cytec Industries Inc.,
West Paterson, New Jersey

CYCOM® 934 Carbon Prepreg

6547

03/27/2006

March 25, 2008

         

Hexion Specialty Chemicals Inc., Houston, Texas

EPI-REZ™ 5522-WY-55

6552

06/03/2007

May 30, 2008

         

Trican Well Services Ltd., Calgary, Alberta

FC-3

6554

November 28, 2005

April 30, 2008

         

Rohm and Haas Canada LP,
West Hill, Ontario

Monomer QM-1458

6566

04/27/2006

January 14, 2008

         

Rohm and Haas Canada LP,
West Hill, Ontario

Monomer QM-1482

6567

04/27/2006

January 14, 2008

         

Rohm and Haas Canada LP,
West Hill, Ontario

Monomer QM-516 Experimental formerly
Monomer QM-516 Exp

6568

04/27/2006

January 31, 2008

         

Rohm and Haas Canada LP,
West Hill, Ontario

Monomer QM-833M

6569

04/27/2006

January 14, 2008

         

Rohm and Haas Canada LP,
West Hill, Ontario

Monomer QM-1326AP

6570

04/27/2006

February 13, 2008

         

Rohm and Haas Canada LP,
West Hill, Ontario

ADVASTAB™ TM-697 Heat Stabilizer

6582

08/04/2006

April 17, 2008

         

Rohm and Haas Canada LP,
West Hill, Ontario

ADVASTAB™ TM-697OM Heat Stabilizer

6583

08/04/2006

April 17, 2008

         

Rohm and Haas Canada LP,
West Hill, Ontario

MORLIFE™ 3300 ASPHALT ADDITIVE

6585

04/27/2006

April 29, 2008

         

Rohm and Haas Canada LP,
West Hill, Ontario

PARALOID™ KM-352 Powder

6586

04/27/2006

April 17, 2008

         

Rohm and Haas Canada LP,
West Hill, Ontario

PARALOID™ KM-346 Impact Modifier

6594

04/27/2006

April 17, 2008

         

Lubrizol Corporation, Wickliffe, Ohio

LUBRIZOL® 5034A

6608

01 November 2007

May 5, 2008

         

E.I. duPont Canada Company, Mississauga, Ontario

ZONYL® 8740

6611

1-May-2006

February 27, 2008

         

Photographic Solutions, Inc., Buzzards Bay, Massachusetts

PEC-12®

6627

15 May, 2006

January 30, 2008

         

Cytec Industries Inc.,
West Paterson, New Jersey

CYCOM® 1003 Prepreg

6640

06/08/2006

March 28, 2008

         

Cytec Industries Inc.,
West Paterson, New Jersey

MXB 997/Glass Prepreg

6641

06/08/2006

March 28, 2008

         

Cytec Industries Inc.,
West Paterson, New Jersey

FM® 94 Prepreg

6642

06/08/2006

March 25, 2008

         

Cytec Industries Inc.,
West Paterson, New Jersey

BR® 626 Potting Compound

6643

04/07/2006

March 28, 2008

         

Cytec Industries Inc.,
West Paterson, New Jersey

CYCOM® 890-1 Prepreg

6644

06/08/2006

March 28, 2008

         

Cytec Industries Inc.,
West Paterson, New Jersey

CYCOM® 890 RTM Resin

6645

06/08/2006

March 28, 2008

         

Innovative Chemical Technologies Canada Ltd.,
Calgary, Alberta

Smart Frac

6654

March 13, 2007

May 9, 2008

         

E.I. duPont Canada Company,
Mississauga, Ontario

“ZONYL” 9933

6667

18-JAN-2008

May 22, 2008

         

Acheson Colloids Company,
Port Huron, Michigan

Emralon 330

6676

5/02/2006 (English) 06/05/02 (French)

February 29, 2008

         

Acheson Colloids Company,
Port Huron, Michigan

GP 1904

6678

5/02/2006 (English) 2006.05.02 (French)

March 27, 2008

         

Acheson Colloids Company,
Port Huron, Michigan

Emralon 329

6680

2/09/2006 (English) 06/02/09 (French)

January 18, 2008

         

Acheson Colloids Company,
Port Huron, Michigan

TA-026B

6682

6/09/2006 (English) 2007/02/05 (French)

May 21, 2008

         

Acheson Colloids Company,
Port Huron, Michigan

LUMIDAG EL-043A

6683

10/18/2007 (English) 06/04/03 (French)

May 16, 2008

         

Acheson Colloids Company,
Port Huron, Michigan

DELTAFORGE 1001

6685

10/09/2007 (English) 07/02/05 (French)

May 21, 2008

         

Acheson Colloids Company,
Port Huron, Michigan

DELTAFORGE 1105

6686

10/25/2007 (English) 07/02/05 (French)

May 21, 2008

         

Hexion Specialty Chemicals Inc.,
Houston, Texas

EPIKURE™ 3380 Curing Agent

6689

06/03/2007

May 30, 2008

         

Hexion Specialty Chemicals Inc.,
Houston, Texas

EPI-REZ™ 3520-WY-55 Resin

6699

06/03/2007

May 30, 2008

         

Lubrizol Corporation,
Wickliffe, Ohio

ADDCO® 370P

6700

04 August 2006

March 28, 2008

         

Innospec Fuel Specialties, LLC
Newark, Delaware

DDA-3565-ff1

6711

07 September 2006

February 27, 2008

         

Henkel Canada Corporation, Mississauga, Ontario formerly
Etobicoke, Ontario

DTI M3-A CUPPER formerlyDTI M3-A Cupper

6712

Jan07/08

May 12, 2008

         

Henkel Canada Corporation, Mississauga, Ontario formerly
Etobicoke, Ontario

DTI C1-A CUPPER formerlyDTI C1-A Cupper

6713

Jan07/08

May 12, 2008

         

Henkel Canada Corporation, Mississauga, Ontario formerly
Etobicoke, Ontario

DTI 8100-A POST LUBE formerly
DTI 8100-A Post Lube

6714

Jan07/08

May 12, 2008

         

Hexion Specialty Chemicals Inc., Houston, Texas

EPIKUREÔ 9551 Curing Agent

6719

06/03/2007

May 30, 2008

         

Raybo Chemical Company, Huntington, West Virginia

RAYBO 57 OPTISPERSE HS

6724

Oct31/07 (English) OCT31/07 (French)

January 18, 2008

         

Raybo Chemical Company, Huntington, West Virginia

RAYBO 85 RUSTIB

6725

Oct31/07 (English) OCT31/07 (French)

January 18, 2008

         

Raybo Chemical Company, Huntington, West Virginia

RAYBO 60 NORUST

6726

Oct31/07 (English) OCT31/07 (French)

March 6, 2008

         

Taylor Technologies, Inc., Sparks, Maryland

DPD REAGENT #2/REACTIF DPD #2

6727

2006/10/12

April 8, 2008

         

Innospec Fuel Specialties, LLC Newark, Delaware

OLI-9101.x

6732

17 October 2006

February 11, 2008

         

Innospec Fuel Specialties, LLC Newark, Delaware

Stadis ® 450

6733

13 October 2006

February 11, 2008

         

Innospec Fuel Specialties, LLC Newark, Delaware

Stadis ® 425

6734

06 October 2006

February 11, 2008

         

Innospec Fuel Specialties, LLC Newark, Delaware

DCI 4A formerly
DCI-4A

6744

26 October 2006

February 11, 2008

         

Innospec Fuel Specialties, LLC Newark, Delaware

DCI 6A formerly
DCI-6A

6745

26 October 2006

February 11, 2008

         

Dow Chemical Canada Inc., Calgary, Alberta

UCON(TM) COMPRESSOR LUBRICANT RSC-155/LUBRIFIANT UCON(MC) RSC-155 POUR COMPRESSEURS

6766

2006.11.15

April 24, 2008

         

Hexion Specialty Chemicals Canada Inc., Oshawa, Ontario

Fentak™ FW0926

6816

12-DEC-2006

May 14, 2008

         

Acheson Colloids Company,
Port Huron, Michigan

LUMIDAG EL-047

6819

10/19/2007 (English) 06/10/10 (French)

March 18, 2008

         

Innovative Chemical Technologies Canada Ltd., Calgary, Alberta

AXE 707C

6822

December 20, 2006

March 31, 2008

         

BYK USA Inc., formerly
BYK-Chemie USA, Inc.,
Wallingford, Connecticut

BYK-9076

6881

11/06/2007

March 31, 2008

         

BYK USA Inc., formerly
BYK-Chemie USA, Inc.,
Wallingford, Connecticut

Disperbyk-130

6882

11/06/2007

April 30, 2008

         

Oxylene Limited, Vancouver, British Columbia

OXYLENE™ Additive

6901

2007 02 15

February 22, 2008

         

Cytec Industries Inc.,
West Paterson, New Jersey

CYCOM® 7701 Structural Prepreg

6908

03/15/2007

February 4, 2008

         

Cytec Industries Inc.,
West Paterson, New Jersey

CYCOM® 3200 Structural Prepreg

6912

03/15/2007

February 4, 2008

         

Cytec Industries Inc.,
West Paterson, New Jersey

CYCOM® 3288 Structural Prepreg

6914

03/15/2007

February 4, 2008

         

Lubrizol Corporation, Wickliffe, Ohio

LUBRIZOL® 5706A

6923

11 December 2007

April 16, 2008

         

Innospec Fuel Specialties, LLC Newark, Delaware formerly
Littleton, Colorado

DCI-11

6949

12 April 2007

March 26, 2008

         

BYK USA Inc., Wallingford, Connecticut

ANTI-TERRA-U 80

7031

06/01/2007

April 30, 2008

         

BYK USA Inc., Wallingford, Connecticut

BYK-W 980

7032

06/01/2007

April 30, 2008

         

Hexion Specialty Chemicals Inc., Houston, Texas

EPIKURE™ 8537-WY-60 Curing Agent

7080

07/20/2007

May 30, 2008

         

Chemtrade Logistics Inc., North York, Ontario

VIRWITE LIQUID (SERIES 200)

7101

8-1-2007

March 14, 2008

         

Chemtrade Logistics Inc., North York, Ontario

VIRWITE LIQUID (SERIES 300)

7102

8-1-2007

March 14, 2008

         

Chemtrade Logistics Inc., North York, Ontario

VIRWITE LIQUID (SERIES 400)

7103

8-1-2007

March 14, 2008

         

Chemtrade Logistics Inc., North York, Ontario

VIRWITE POWDER (SERIES 200)

7104

8-1-2007

January 29, 2008

         

Chemtrade Logistics Inc., North York, Ontario

VIRWITE POWDER (SERIES 300A)

7105

8-1-2007

January 29, 2008

         

Chemtrade Logistics Inc., North York, Ontario

VIRWITE POWDER (SERIES 300B)

7106

8-1-2007

January 29, 2008

Notes: 1. The Notice of Filing published in the Canada Gazette, Part I, on May 21, 2005, listed the subject of the claim bearing Registry Number 6183 to be the chemical identity and concentration of four ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity and concentration of two ingredients.

2. The Notice of Filing published in the Canada Gazette, Part I, on July 8, 2005, listed the subject of the claim bearing Registry Number 6238 to be the chemical identity and concentration of four ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity and concentration of one ingredient.

3. The Notice of Filing published in the Canada Gazette, Part I, on November 12, 2005, listed the subject of the claim bearing Registry Number 6246 to be the chemical identity of one ingredient. The subject of the claim on which the screening officer issued the decision is the chemical identity of two ingredients.

4. The Notice of Filing published in the Canada Gazette, Part I, on November 12, 2005, listed the subject of the claim bearing Registry Number 6274 to be the chemical identity of four ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of six ingredients.

5. The Notice of Filing published in the Canada Gazette, Part I, on February 4, 2006, listed the subject of the claim bearing Registry Number 6277 to be the chemical identity of two ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of four ingredients.

6. The Notice of Filing published in the Canada Gazette, Part I, on February 4, 2006, listed the subject of the claim bearing Registry Number 6304 to be the chemical identity and concentration of three ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity and concentration of four ingredients.

7. The Notice of Filing published in the Canada Gazette, Part I, on April 1, 2006, listed the subject of the claim bearing Registry Number 6468 to be the chemical identity of two ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of three ingredients.

8. The Notice of Filing published in the Canada Gazette, Part I, on April 1, 2006, listed the subject of the claim bearing Registry Number 6476 to be the chemical identity and concentration of one ingredient. The subject of the claim on which the screening officer issued the decision is the concentration of one ingredient.

9. The Notice of Filing published in the Canada Gazette, Part I, on April 1, 2006, listed the subject of the claims bearing Registry Numbers 6477 and 6478 to be the chemical identity of five ingredients. The subject of the claims on which the screening officer issued the decisions is the chemical identity of six ingredients and the concentration of seven ingredients.

10. The Notice of Filing published in the Canada Gazette, Part I, on April 1, 2006, listed the subject of the claim bearing Registry Number 6491 to be the chemical identity of two ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of one ingredient.

11. The Notice of Filing published in the Canada Gazette, Part I, on April 1, 2006, listed the subject of the claims bearing Registry Numbers 6497, 6498 and 6499 to be the chemical identity of two ingredients. The subject of the claims on which the screening officer issued the decisions is the chemical identity of three ingredients.

12. The Notice of Filing published in the Canada Gazette, Part I, on April 1, 2006, listed the subject of the claim bearing Registry Number 6500 to be the chemical identity of two ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of four ingredients.

13. The Notice of Filing published in the Canada Gazette, Part I, on April 1, 2006, made no mention of the subject of the claim bearing Registry Number 6501. The subject of the claim on which the screening officer issued the decision is the chemical identity of four ingredients.

14. The Notice of Filing published in the Canada Gazette, Part I, on April 1, 2006 listed the subject of the claim bearing Registry Number 6502 to be the chemical identity of three ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of four ingredients.

15. The Notice of Filing published in the Canada Gazette, Part I, on April 1, 2006, listed the subjects of the claims bearing Registry Numbers 6503, 6504 and 6505 to be the chemical identity of three, two and two ingredients respectively. The subjects of the claims on which the screening officer issued the decisions are the chemical identity of four, three and three ingredients, respectively.

16. The Notice of Filing published in the Canada Gazette, Part I, on April 1, 2006, listed the subjects of the claims bearing Registry Numbers 6506, 6507 and 6508 to be the chemical identity of two, three and two ingredients, respectively. The subjects of the claims on which the screening officer issued the decisions are the chemical identity of three, five and four ingredients, respectively.

17. The Notice of Filing published in the Canada Gazette, Part I, on April 1, 2006, listed the subject of the claims bearing Registry Numbers 6509 and 6510 to be the chemical identity of two ingredients. The subject of the claims on which the screening officer issued the decisions is the chemical identity of three ingredients.

18. The Notice of Filing published in the Canada Gazette, Part I, on April 1, 2006, listed the subject of the claims bearing Registry Numbers 6511 through 6514, 6516, 6517 and 6519 through 6524 to be the chemical identity of two ingredients. The subject of the claims on which the screening officer issued the decisions is the chemical identity of three ingredients.

19. The Notice of Filing published in the Canada Gazette, Part I, on April 1, 2006, listed the subject of the claims bearing Registry Numbers 6515 and 6518 to be the chemical identity of three ingredients. The subject of the claims on which the screening officer issued the decisions is the chemical identity of five ingredients.

20. The Notice of Filing published in the Canada Gazette, Part I, on April 1, 2006, listed the subject of the claim bearing Registry Number 6534 to be the chemical name, common name, generic name, trade name or brand name of a controlled product of one ingredient. The subject of the claim on which the screening officer issued the decision is the trade name and information which could be used to identify the supplier of a controlled product. The Notice also incorrectly listed the product identifier for the controlled product associated with the claim bearing Registry Number 6534 as CAN1000. The correct product identifier is CAN-1000.

21. The Notice of Filing published in the Canada Gazette, Part I, on April 1, 2006, listed the subject of the claim bearing Registry Number 6538 to be the chemical name, common name, generic name, trade name or brand name of a controlled product of four ingredients. The subject of the claim on which the screening officer issued the decision is the trade name and information which could be used to identify the supplier of a controlled product. The Notice also incorrectly listed the product identifier for the controlled product associated with the claim bearing Registry Number 6538 as CAN1100. The correct product identifier is CAN-1100.

22. The Notice of Filing published in the Canada Gazette, Part I, on April 1, 2006, listed the subject of the claims bearing Registry Numbers 6539 and 6540 to be the chemical name, common name, generic name, trade name or brand name of a controlled product of five ingredients. The subject of the claims on which the screening officer issued the decisions is the trade name and information which could be used to identify the supplier of a controlled product. The Notice also incorrectly listed the product identifiers for the controlled product associated with the claims bearing Registry Numbers 6539 and 6540 as RS CLEAN S and RS CLEAN PA, respectively. The correct product identifiers are Res-Clean S and Res-Clean PA, respectively.

23. The Notice of Filing published in the Canada Gazette, Part I, on April 1, 2006, listed the subject of the claim bearing Registry Number 6552 to be the chemical identity of two ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of one ingredient.

24. The Notice of Filing published in the Canada Gazette, Part I, on July 15, 2006, listed the subject of the claim bearing Registry Number 6554 to be the chemical name, common name, generic name, trade name or brand name of a controlled product and information which could be used to identify the supplier of a controlled product of one ingredient. It also identified the claim as seeking exemption from the disclosure of employer confidential information in respect of a controlled product which would otherwise be required to be disclosed by the provisions of the applicable provincial legislation relating to occupational health and safety.

It has since been established that the subject of the claim is the chemical identity of one ingredient and the claim is seeking exemption from the disclosure of supplier confidential business information in respect of a controlled product; such disclosure would otherwise be required under the provisions of the Hazardous Products Act. The screening officer issued the decision on that basis.

25. The Notice of Filing published in the Canada Gazette, Part I, on July 15, 2006, listed the subject of the claim bearing Registry Number 6567 to be the chemical identity of one ingredient. The subject of the claim on which the screening officer issued the decision is the chemical identity of two ingredients.

26. The Notice of Filing published in the Canada Gazette, Part I, on July 15, 2006, listed the subject of the claim bearing Registry Number 6608 to be the chemical identity of two ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of four ingredients.

27. The Notice of Filing published in the Canada Gazette, Part I, on July 15, 2006, listed the subject of the claim bearing Registry Number 6611 to be the chemical identity and concentration of one ingredient. The subject of the claim on which the screening officer issued the decision is the chemical identity of one ingredient.

28. The Notice of Filing published in the Canada Gazette, Part I, on July 15, 2006, listed the subject of the claim bearing Registry Number 6627 to be the chemical identity of two ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of three ingredients.

29. The Notice of Filing published in the Canada Gazette, Part I, on July 15, 2006, listed the subject of the claim bearing Registry Number 6654 to be the chemical identity of one ingredient and the chemical identity and concentration of four ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of two ingredients and the concentration of three ingredients.

30. The Notice of Filing published in the Canada Gazette, Part I, on December 2, 2006, listed the subject of the claim bearing Registry Number 6699 to be the chemical identity of three ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of two ingredients.

31. The Notice of Filing published in the Canada Gazette, Part I, on December 2, 2006, listed the subject of the claims bearing Registry Numbers 6711 and 6766 to be the chemical identity of two ingredients. The subject of the claims on which the screening officer issued the decisions is the chemical identity of one ingredient.

32. The Notice of Filing published in the Canada Gazette, Part I, on March 24, 2007, listed the subject of the claim bearing Registry Number 6822 to be the chemical identity of two ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of two ingredients and the concentration of three ingredients.

33. The Notice of Filing published in the Canada Gazette, Part I, on March 24, 2007, listed the subject of the claims bearing Registry Numbers 6881 and 6882 to be the chemical identity and concentration of one ingredient. The subject of the claims on which the screening officer issued the decisions is the concentration of one ingredient.

34. The Notice of Filing published in the Canada Gazette, Part I, on June 30, 2007, listed the subject of the claim bearing Registry Number 6908 to be the chemical identity of two ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of three ingredients.

35. The Notice of Filing published in the Canada Gazette, Part I, on September 8, 2007, listed the subjects of the claims bearing Registry Numbers 7101, 7102, 7103, 7104, 7105 and 7106 to be the chemical identity and concentration of four, four, two, two, three and three ingredients, respectively. The subjects of the claims on which the screening officer issued the decisions are the chemical identity and the concentration of two, two, one, one, two and two ingredients, respectively.

There were no submissions from affected parties to the screening officer with respect to any of the above claims for exemption and related MSDSs or labels.

Each of the claims for exemption listed above was found to be valid. The screening officer reached this decision after reviewing the information in support of the claim, having regard exclusively to the criteria found in section 3 of the Hazardous Materials Information Review Regulations. Having regard for the various data readily available in the literature and any information provided by the claimant, the screening officer found that the respective MSDS in respect of which the claims bearing Registry Numbers 6410, 6492, 6493, 6586, 6594, 6724 and 6766 were filed complied with the applicable disclosure requirements of the Hazardous Products Act and the Controlled Products Regulations.

In the case of the claims bearing Registry Numbers 6231, 6566, 6567, 6568, 6569 and 6570, being claims from employers in the province of Ontario, the screening officer found that the MSDSs relating to these claims and the label relating to the claim bearing Registry Number 6231 did not comply with the applicable disclosure requirements of the Occupational Health and Safety Act of the Province of Ontario.

In the case of the claims bearing Registry Numbers 6411, 6487, 6534, 6538, 6539 and 6540, being claims from employers in the province of Alberta, the screening officer found that the MSDSs relating to these claims and the labels relating to the claims bearing Registry Numbers 6411, 6534, 6538, 6539 and 6540 did not comply with the applicable disclosure requirements of the Occupational Health and Safety Code 2006 of the Province of Alberta.

Having regard for the various data readily available in the literature and any information provided by the claimant, the screening officer found that the respective MSDS in respect of which the remaining claims were filed did not comply with the applicable disclosure requirements of the Hazardous Products Act and the Controlled Products Regulations.

Registry Number 6082

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Remove the concentration range shown for the confidential hazardous ingredient severely hydrotreated naphthenic petroleum distillates and disclose its actual concentration or an acceptable range value;

2. Disclose an LD50 (oral, rat) value of 1 720 mL/kg and an LD50 (dermal, rabbit) value of 1.00 mL/kg for monoethanolamine;

3. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class E;

4. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for at least 30 minutes;

5. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed continuously with water for 30 minutes;

6. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two glasses of water or milk to drink. Add information to the effect that no attempt should be made to give anything by mouth to a person who is rapidly losing consciousness, or is unconscious or convulsing, and that if vomiting occurs naturally, have the casualty lean forward to reduce the risk of aspiration.

Registry Number 6183

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the percent concentration of sodium hydrosulfite in an acceptable manner;

2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that contaminated clothing, shoes and leather goods should be removed under running water;

3. Remove the statement indicating that the controlled product is slightly to moderately irritating as opposed to being a corrosive material.

Registry Numbers 6221 to 6223, inclusive

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Disclose the Exposure Limit Values ACGIH TLV–TWA = 200 ppm and ACGIH TLV–STEL = 300 ppm for 2-butanone;

2. Add hydrogen chloride to the list of hazardous decomposition products;

3. Registry Number 6221: Disclose the percent concentration of
2-butanone in an acceptable manner;

4. Registry Number 6222: Disclose the presence of two additional hazardous ingredients in the controlled product, together with their CAS registry numbers and percent concentrations;

5. Registry Number 6223:

(a) Disclose the percent concentration of titanium dioxide in an acceptable manner;

(b) Add oxides of nitrogen and sulphur to the list of hazardous decomposition products;

(c) Disclose that an ingredient in the controlled product has been classified as possibly carcinogenic to humans (Group 2B) by the International Agency for Research on Cancer (IARC).

Registry Number 6224

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Disclose the percent concentration of acetone in an acceptable manner;

2. Disclose the presence of an additional hazardous ingredient in the controlled product, together with its percent concentration;

3. Add oxides of chlorine to the list of hazardous combustion products.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Registry Number 6225

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the percent concentrations of aniline derivative and poly(aromatic glycidyl ether) in an acceptable manner;

2. Disclose the presence of an additional hazardous ingredient in the controlled product, together with its percent concentration;

3. Add oxides of chlorine to the list of hazardous combustion products;

4. Disclose that exposure to diglycidyl ether of bisphenol A has caused respiratory sensitization in workers;

5. Disclose that the monocyclic organic compound has been shown to cause dermal sensitization in laboratory animals.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Registry Number 6226

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the presence of an additional hazardous ingredient in the controlled product, together with its CAS registry number, percent concentration, ACGIH Exposure Limit Value and the fact that it has been classified as possibly carcinogenic to humans (Group 2B) by the International Agency for Research on Cancer (IARC);

2. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in mammalian and bacterial cells in vitro;

3. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2B.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Registry Number 6227

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the percent concentration of methylene chloride in an acceptable manner;

2. Disclose the presence of an additional hazardous ingredient in the controlled product, together with its percent concentration;

3. Disclose the Exposure Limit Value AIHA WEEL–TWA = 1 mg/m3 for the acrylic monomer;

4. Add oxides of chlorine to the list of hazardous combustion products;

5. Disclose an LC50 value for one of the confidential hazardous ingredients in an acceptable manner;

6. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in mammalian and bacterial cells in vitro;

7. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1A.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Registry Number 6228

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Disclose the presence of an additional hazardous ingredient in the controlled product, together with its percent concentration;

2. Disclose the presence of a second additional hazardous ingredient in the controlled product, together with its CAS registry number, percent concentration and the fact that it has been classified as possibly carcinogenic to humans (Group 2B) by the International Agency for Research on Cancer (IARC);

3. Add oxides of sulphur and chlorine to the list of hazardous combustion products;

4. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2A.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Registry Number 6230

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the presence of an additional hazardous ingredient in the controlled product, together with its percent concentration.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Registry Number 6231

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for at least 30 minutes;

2. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed continuously with water for 30 minutes;

3. In relation to the first aid information shown on the MSDS for ingestion, add a statement such as the following: If vomiting occurs naturally, have casualty lean forward to reduce the risk of aspiration;

In the opinion of the screening officer, certain information should also have been shown on the label. The claimant has been ordered to amend the label as indicated below.

1. Disclose the HMIRC registry number and the date of the decision granting the exemption;

2. In relation to the first aid information shown on the label for skin contact, disclose a statement to the effect that the skin should be washed with water for at least 30 minutes;

3. In relation to the first aid information shown on the label for eye contact, disclose a statement to the effect that the eyes should be flushed continuously with water for 30 minutes;

4. In relation to the first aid information shown on the label for ingestion, add a statement such as the following: If vomiting occurs naturally, have casualty lean forward to reduce the risk of aspiration.

Registry Number 6235

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed with water for at least 20 minutes or until the chemical is removed;

2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;

3. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two glasses of water to drink and add advice to the effect that the casualty should lean forward should vomiting occur in order to reduce the risk of aspiration;

4. Disclose an LD50 (dermal, rabbit) value of 1.58 mL/kg for
2-butoxyethyl acetate;

5. Disclose that an ingredient in the controlled product has shown positive test results in an in vivo screening test for mutagenicity.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Registry Number 6238

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

Registry Number 6246

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the presence of an additional confidential hazardous ingredient in the controlled product, together with its percent concentration;

2. Disclose the presence of oleic acid in the controlled product, its CAS Registry Number 112-80-1 and its percent concentration.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Registry Numbers 6249 to 6251, inclusive

The claimant has been ordered to amend certain aspects of the format of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Registry Number 6250: In section 11, correctly disclose that the value of 1 862 mg/kg (oral mouse) is an LD50 rather than an LDLo value;

2. Registry Number 6251:

(a) In relation to the first aid information shown on the MSDS for ingestion, clarify that fluid is to be administered only under medical supervision;

(b) In relation to the period of time shown on the MSDS for flushing the eyes with water should eye contact occur, delete the current reference to “fifteen minutes” and replace it with a time of “from fifteen to thirty minutes.”

Registry Number 6261

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Delete the statement which indicates that the ingredient zinc alkyldithiophosphate is a WHMIS confidential ingredient;

2. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed continuously with water for at least 15 minutes;

3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with soap and water for at least 15 minutes;

4. Add oxides of nitrogen to the list of hazardous thermal decomposition products;

5. Remove the statement that the controlled product does not meet the criteria for a classification of D2B as an eye irritant.

Registry Numbers 6274 and 6277

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the presence of two additional confidential hazardous ingredients in the controlled product, together with their percent concentrations;

2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement indicating one should give large quantities of water to drink;

3. Disclose oxides of carbon, phosphorus and nitrogen as hazardous combustion products;

4. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1A;

5. Registry Number 6274:

(a) Disclose that an ingredient in the controlled product has shown positive results in a screening test for mutagenicity;

(b) In relation to the first aid information shown on the MSDS for inhalation, disclose a statement to the effect that trained personnel should immediately administer cardiopulmonary resuscitation if the heart has stopped;

(c) In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;

(d) Disclose a lower LD50 (oral, rat) value of 2.46 mL/kg and a lower LD50 (dermal, rabbit) value of 2.38 mL/kg for 2-ethylhexanol;

(e) Disclose a lower LD50 (dermal, rabbit) value of 400 mg/kg and an LC50 (4 hours, rat) value of 450 ppm for one of the confidential hazardous ingredients.

Registry Number 6283

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for at least 15 minutes.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Registry Number 6287

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Add oxides of sulphur to the list of hazardous combustion products;

2. Disclose that acute ingestion of an ingredient of the controlled product has been shown to cause adverse central nervous system (CNS) effects;

3. Disclose that an ingredient in the controlled product has been shown to cause fetotoxic effects in laboratory animals.

Registry Numbers 6290 and 6292

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Add inhalation and ingestion as routes of entry;

2. Disclose an LD50 (oral, rat) value of 2.46 mL/kg for 2-ethylhexanol;

3. Disclose that an ingredient in the controlled product has been shown to cause fetotoxic effects in laboratory animals;

4. Disclose that acute ingestion of an ingredient in the controlled product has been shown to cause adverse effects on the thymus, spleen and the immune system in laboratory animals;

5. Disclose that acute ingestion of ingredients in the controlled product has been shown to cause adverse CNS effects in laboratory animals;

6. Disclose that ingestion of an ingredient in the controlled product has been shown to cause irritation to the gastrointestinal tract in laboratory animals;

7. Disclose that chronic ingestion of an ingredient in the controlled product has been shown to cause adverse effects on the prostate and the immune system of laboratory animals;

8. Registry Number 6290: Disclose an LD50 value for the confidential hazardous ingredient in an acceptable manner;

9. Registry Number 6292:

(a) Correct the impression that naphthalene and
1,2,4-trimethylbenzene are regulated components of the controlled product;

(b) Disclose an LD50 (oral, rat) value of 3 200 mg/kg for solvent naphtha petroleum, heavy aromatic;

(c) Disclose LD50 values for one of the confidential hazardous ingredients in an acceptable manner;

(d) Disclose that acute dermal exposure to an ingredient in the controlled product has been shown to cause CNS effects in laboratory animals.

Registry Number 6293

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Add oxides of sulphur to the list of hazardous combustion products;

2. Disclose that acute ingestion of an ingredient of the controlled product has been shown to cause adverse CNS effects;

3. Disclose that an ingredient in the controlled product has been shown to cause fetotoxic effects in laboratory animals.

Registry Numbers 6294 and 6295

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Add inhalation and ingestion as routes of entry;

2. Correct the impression that naphthalene and 1,2,4trimethylbenzene are regulated components of the controlled product;

3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for 20 minutes or until the chemical is removed;

4. Disclose an LD50 (oral, rat) value of 3 200 mg/kg for solvent naphtha petroleum, heavy aromatic;

5. Disclose that ingredients in the controlled product have been shown to cause fetotoxic effects in laboratory animals;

6. Disclose that ingestion of an ingredient in the controlled product potentiates the hepatotoxicity of carbon tetrachloride;

7. Disclose that acute ingestion of an ingredient of the controlled product has been shown to cause CNS effects in laboratory animals;

8. Remove the statement that the controlled product is practically non-toxic in contact with the skin;

9. Registry Number 6294:

(a) Add oxides of nitrogen and sulphur to the list of hazardous combustion products;

(b) Disclose an LD50 value for the confidential hazardous ingredient in an acceptable manner;

(c) Disclose that acute dermal exposure to an ingredient in the controlled product has been shown to cause CNS effects in laboratory animals;

(d) Disclose that acute inhalation of an ingredient in the controlled product has caused central nervous system effects and irritation to the respiratory tract in laboratory animals;

(e) Disclose that chronic ingestion of ingredients in the controlled product has been shown to cause CNS effects, gastrointestinal disturbances and adverse effects on the blood, kidney and liver of laboratory animals;

(f) Disclose that an ingredient in the controlled product has been shown to be a moderate skin irritant in rabbits;

10. Registry Number 6295: Disclose LD50 values for one of the confidential hazardous ingredients in an acceptable manner.

Registry Numbers 6296 and 6297

The claimant has been ordered to amend certain aspects of the content and wording of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Correct the impression that naphthalene and
1,2,4-trimethylbenzene are regulated components of the controlled product;

2. Disclose LD50 values for one of the confidential hazardous ingredients in an acceptable manner;

3. Disclose an LD50 (oral, rat) value of 3 200 mg/kg for solvent naphtha petroleum, heavy aromatic;

4. Disclose that an ingredient in the controlled product has been shown to cause fetotoxic effects in laboratory animals;

5. Registry Number 6297:

(a) Add oxides of nitrogen and sulphur to the list of hazardous combustion products;

(b) Disclose an LD50 value for a second confidential hazardous ingredient in an acceptable manner;

(c) Disclose that acute dermal exposure to an ingredient in the controlled product has been shown to cause CNS effects in laboratory animals;

(d) Disclose that acute ingestion of an ingredient of the controlled product has been shown to cause harmful effects on the central nervous, gastrointestinal and respiratory systems.

Registry Numbers 6298 and 6299

The claimant has been ordered to amend certain aspects of the format and wording of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Add oxides of nitrogen and sulphur to the list of hazardous combustion products;

2. Disclose LD50 values for one of the confidential hazardous ingredients in an acceptable manner;

3. Disclose that acute ingestion of an ingredient of the controlled product has been shown to cause harmful effects on the central nervous, gastrointestinal and respiratory systems;

4. Disclose that an ingredient in the controlled product has been shown to cause fetotoxic effects in laboratory animals;

5. Registry Number 6298: In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for 20 minutes or until the chemical is removed;

6. Registry Number 6299: Disclose an LD50 value for a second confidential hazardous ingredient in an acceptable manner.

Registry Numbers 6300 and 6302

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Correct the impression that naphthalene and
1,2,4-trimethylbenzene are regulated components of the controlled product;

2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for 20 minutes or until the chemical is removed;

3. Add oxides of nitrogen and sulphur to the list of hazardous combustion products;

4. Disclose that acute ingestion of an ingredient of the controlled product has been shown to cause harmful effects on the central nervous and respiratory systems in laboratory animals;

5. Registry Number 6302:

(a) Disclose that dermal exposure to an ingredient in the controlled product has been shown to cause skin irritation and CNS effects in laboratory animals;

(b) If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in classes D2B and B3.

Registry Number 6303

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Disclose an LD50 value for one of the confidential hazardous ingredients in an acceptable manner;

2. Disclose that chronic ingestion of an ingredient in the controlled product has been shown to cause adverse effects on the gastrointestinal system and cause growth retardation in laboratory animals;

3. Disclose that acute ingestion of an ingredient of the controlled product has been shown to cause adverse CNS effects and gastrointestinal tract disturbances;

4. Disclose that acute inhalation of high doses of an ingredient in the controlled product has been shown to cause CNS depression and adverse lung effects in laboratory animals;

5. Disclose that ingestion of an ingredient in the controlled product potentiates the hepatotoxicity of carbon tetrachloride;

6. Disclose that ingestion of an ingredient in the controlled product potentiates the hepatotoxicity of carbon tetrachloride and chloroform.

Registry Number 6304

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Correct the impression that naphthalene and
1,2,4-trimethylbenzene are regulated components of the controlled product;

2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for 20 minutes or until the chemical is removed;

3. Disclose that acute ingestion of an ingredient of the controlled product has been shown to cause harmful effects on the central nervous and respiratory systems in laboratory animals;

4. Disclose that dermal exposure to an ingredient in the controlled product has been shown to cause skin irritation and CNS effects in laboratory animals.

Registry Number 6305

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Correct the impression that naphthalene is a regulated component of the controlled product;

2. Add inhalation and ingestion as routes of entry;

3. Disclose an LD50 (oral, rat) value of 3 200 mg/kg for solvent naphtha (petroleum), heavy aromatic;

4. Disclose that an ingredient in the controlled product has been shown to cause fetotoxic effects in laboratory animals;

5. Disclose that ingestion of an ingredient in the controlled product potentiates the hepatotoxicity of carbon tetrachloride.

Registry Numbers 6317 and 6318

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Disclose the presence of hydrotreated light naphthenic distillates in the controlled product, their CAS Registry Number 64742-53-6 and their percent concentration;

2. Disclose an LC50 (4 hours, rat, aerosol) value of 2 180 mg/m3 for hydrotreated light naphthenic distillates;

3. In relation to the first aid information shown on the MSDS for inhalation, disclose a statement to the effect that trained personnel should immediately administer cardiopulmonary resuscitation if the heart has stopped;

4. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1B.

Registry Number 6411

The claimant has been ordered to amend certain aspects of the format of the MSDS.

In the opinion of the screening officer, certain information should also have been shown on the label. The claimant has been ordered to amend the label as indicated below.

1. Disclose the HMIRC registry number.

Registry Number 6412

The claimant has been ordered to amend certain aspects of the format of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose that an ingredient in the controlled product has been shown to be corrosive to the skin of laboratory animals;

2. In relation to the first aid information shown on the MSDS for ingestion, add a statement such as the following: If vomiting occurs naturally, have casualty lean forward to reduce the risk of aspiration;

3. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class E.

Registry Number 6418

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Disclose the lower LD50 (dermal, rabbit) value of 3.44 mL/kg for
2-phenoxyethanol.

Registry Number 6425

The claimant has been ordered to amend certain aspects of the format of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed with large amounts of water for at least 30 minutes;

2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with large amounts of water for at least 30 minutes;

3. In relation to the first aid information shown on the MSDS for ingestion, remove the statement indicating one should give large quantities of water to drink. Add a statement such as the following: If vomiting occurs naturally, have casualty lean forward to reduce the risk of aspiration.

Registry Number 6437

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the percent concentration of certain of the hazardous ingredients in an acceptable manner;

2. In relation to the first aid information shown on the MSDS for eye contact, disclose that flushing should continue for at least 60 minutes;

3. In relation to the first aid information shown on the MSDS for skin contact, disclose that flushing should continue for at least 60 minutes and that medical attention should be obtained immediately.

Registry Number 6438

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. In relation to the period of time shown on the MSDS for flushing the skin with water should skin contact occur, delete the current reference to at least fifteen minutes and replace it with a time of “at least thirty minutes.”

Registry Number 6468

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Disclose the presence of an additional confidential hazardous ingredient in the controlled product, together with its percent concentration;

2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for at least 20 minutes or until the chemical is removed;

3. Disclose that metal containers should be grounded when transferring large quantities of the controlled product.

Registry Number 6469

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Disclose the percent concentrations of epoxy/phenolic resin and phenolic epoxy resin in an acceptable manner;

2. Add oxides of nitrogen to the list of hazardous decomposition products.

Registry Number 6470

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Disclose the presence of an additional hazardous ingredient in the controlled product, together with its CAS registry number and percent concentration;

2. Correct the impression that tetrabromobisphenol A is a regulated component of the controlled product;

3. Add hydrogen chloride to the list of hazardous decomposition products;

4. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2A.

Registry Number 6471

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Disclose the presence of an additional confidential hazardous ingredient in the controlled product;

2. Add hydrogen chloride to the list of hazardous decomposition products.

Registry Number 6476

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose an LC50 (4 hours, female rat) value of 450 ppm for
2-butoxyethanol;

2. Disclose that an ingredient in the controlled product has been shown to cause fetotoxic effects in laboratory animals;

3. Disclose that an ingredient in the controlled product has shown positive results in screening tests for mutagenicity.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Registry Numbers 6476 and 6477

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the presence of two additional confidential hazardous ingredients in the controlled product;

2. Disclose the Exposure Limit Value ACGIH TLV–TWA = 0.2 ppm for the confidential hazardous ingredient acid 2;

3. Disclose a lower oral LD50 value for one of the confidential hazardous ingredients in an acceptable manner;

4. Disclose a lower bound to the dermal LD50 value for another of the confidential hazardous ingredients;

5. Disclose a lower bound to the oral LD50 value for a third confidential hazardous ingredient;

6. In relation to the first aid information shown on the MSDS for skin contact, disclose that immediate medical attention should be sought in all cases, and that flushing should continue for at least 30 minutes;

7. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed continuously with water for 30 minutes;

8. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two glasses of water to drink and add advice to the effect that the casualty should lean forward should vomiting occur in order to reduce the risk of aspiration. Disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;

9. Add oxides of sulphur to the list of hazardous combustion products;

10. Correctly disclose the information pertaining to hazardous decomposition products and incompatible substances relative to the pertinent subheadings;

11. Disclose that a second ingredient in the controlled product has been shown to cause teratogenic effects in laboratory animals.

Acknowledgement: Subsequent to the review of the MSDSs-of-Record respecting these particular claims, the claimant provided the Commission with copies of revised versions. These revised versions of the MSDSs were not, however, reviewed by the screening officer.

Registry Number 6487

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Disclose the presence of an additional confidential hazardous ingredient in the controlled product, together with its percent concentration;

2. Correct the impression that naphthalene and oxyalkylated alcohol (1) are regulated components of the controlled product;

3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for at least 20 minutes or until the chemical is removed;

4. In relation to the first aid information shown on the MSDS for ingestion, disclose advice to the effect that the casualty should lean forward should vomiting occur in order to reduce the risk of aspiration. Also disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;

5. Remove the ACGIH TLV designation from the disclosed exposure limit value for nuisance dusts.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Registry Number 6488

The claimant has been ordered to amend certain aspects of the format of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two glasses of water to drink.

Registry Number 6491

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Correct the impression that “paraffin waxes” are a regulated component of the controlled product.

Registry Number 6495

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose that acute ingestion of an ingredient in the controlled product has been shown to cause CNS effects in laboratory animals;

2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with soap and water for at least 30 minutes;

3. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed continuously with lukewarm, gently flowing water for at least 30 minutes;

4. Disclose an LD50 (dermal, rabbit) value of 3 400 mg/kg for isobutanol.

Registry Numbers 6497 to 6499, inclusive

The claimant has been ordered to amend certain aspects of the format, content and wording of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the presence of xylene in the controlled product, its CAS Registry Number 1330-20-7 and its percent concentration;

2. Disclose that a second ingredient in the controlled product has been shown to cause teratogenic effects in laboratory animals;

3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for at least 20 minutes or until the chemical is removed;

4. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two glasses of water to drink;

5. Add oxides of nitrogen and sulphur to the list of hazardous combustion products;

6. Disclose the Exposure Limit Values ACGIH TLV–TWA = 100 ppm and ACGIH TLV–STEL = 150 ppm for xylene;

7. Registry Numbers 6497 and 6499:

(a) Disclose an LD50 (oral, rat) value of 1.26 g/kg and an LD50 (dermal, rabbit) value of 2.03 mL/kg for 2-phenoxyethanol;

(b) Disclose that both oral and dermal exposure to an ingredient in the controlled product have been shown to cause adverse effects on red blood cells in laboratory animals;

(c) Disclose that dermal exposure to an ingredient in the controlled product has been shown to cause adverse CNS effects;

8. Registry Numbers 6498 and 6499: Disclose that an ingredient in the controlled product is considered to be a somatic cell mutagen based on positive results in an in vivo screening test.

Registry Number 6500

The claimant has been ordered to amend certain aspects of the format, content and wording of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the presence of xylene in the controlled product, its CAS Registry Number 1330-20-7 and its percent concentration;

2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for at least 20 minutes or until the chemical is removed;

3. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two glasses of water to drink;

4. Add oxides of nitrogen and sulphur to the list of hazardous combustion products;

5. Disclose the Exposure Limit Values ACGIH TLV–TWA = 100 ppm and ACGIH TLV–STEL = 150 ppm for xylene;

6. Disclose an LD50 (oral, rat) value of 1.26 g/kg and an LD50 (dermal, rabbit) value of 2.03 mL/kg for 2-phenoxyethanol;

7. Disclose that dermal exposure to an ingredient in the controlled product has been shown to cause adverse CNS effects;

8. Disclose that an ingredient in the controlled product is considered to be a somatic cell mutagen based on positive results in an in vivo screening test;

9. Disclose that both oral and dermal exposure to an ingredient in the controlled product have been shown to cause adverse effects on red blood cells in laboratory animals.

Registry Numbers 6501 and 6502

The claimant has been ordered to amend certain aspects of the content and wording of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the presence of xylene in the controlled product, its CAS Registry Number 1330-20-7 and its percent concentration;

2. Disclose that a second ingredient in the controlled product has been shown to cause teratogenic effects in laboratory animals;

3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for at least 20 minutes or until the chemical is removed;

4. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two glasses of water to drink;

5. Disclose an LD50 (oral, rat) value of 1 694 mg/kg and an LD50 (dermal, rabbit) value of 6 929 mg/kg for the confidential hazardous ingredient photoinitiator;

6. Disclose the Exposure Limit Values ACGIH TLV–TWA = 100 ppm and ACGIH TLV–STEL = 150 ppm for xylene.

Acknowledgement: Subsequent to the review of the MSDSs-of-Record respecting these particular claims, the claimant provided the Commission with copies of revised versions. These revised versions of the MSDSs were not, however, reviewed by the screening officer.

Registry Numbers 6503 to 6505, inclusive

The claimant has been ordered to amend certain aspects of the format, content and wording of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the presence of xylene in the controlled product, its CAS Registry Number 1330-20-7 and its percent concentration;

2. Disclose that a second ingredient in the controlled product has been shown to cause teratogenic effects in laboratory animals;

3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for at least 20 minutes or until the chemical is removed;

4. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two glasses of water to drink;

5. Disclose the Exposure Limit Values ACGIH TLV–TWA = 100 ppm and ACGIH TLV–STEL = 150 ppm for xylene;

6. Registry Number 6503:

(a) Add oxides of nitrogen to the list of hazardous combustion products;

(b) Disclose an LD50 (oral, rat) value of 1.26 g/kg and an LD50 (dermal, rabbit) value of 2.03 mL/kg for 2-phenoxyethanol;

(c) Disclose an LD50 (oral, rat) value of 1 694 mg/kg and an LD50 (dermal, rabbit) value of 6 929 mg/kg for the confidential hazardous ingredient photoinitiator;

(d) Disclose that both oral and dermal exposure to an ingredient in the controlled product have been shown to cause adverse effects on red blood cells in laboratory animals;

(e) Disclose that dermal exposure to an ingredient in the controlled product has been shown to cause adverse CNS effects;

7. Registry Numbers 6404 and 6405:

(a) Correct the implication that ethylbenzene is an ingredient of the controlled product;

(b) Add oxides of nitrogen and sulphur to the list of hazardous combustion products.

Registry Numbers 6506 to 6508, inclusive

The claimant has been ordered to amend certain aspects of the format, content and wording of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for at least 20 minutes or until the chemical is removed;

2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two glasses of water to drink;

3. Add oxides of nitrogen and sulphur to the list of hazardous combustion products;

4. Disclose that dermal exposure to an ingredient in the controlled product has been shown to cause adverse CNS effects;

5. Registry Number 6506: Correctly identify the ACGIH TLV–TWA and TLV–STEL values for the ingredient xylene;

6. Registry Number 6507:

(a) Disclose an LD50 (oral, rat) value of 1.26 g/kg and an LD50 (dermal, rabbit) value of 2.03 mL/kg for 2-phenoxyethanol;

(b) Disclose that both oral and dermal exposure to an ingredient in the controlled product have been shown to cause adverse effects on red blood cells in laboratory animals;

7. Registry Number 6508:

(a) Disclose the presence of xylene in the controlled product, its CAS Registry Number 1330-20-7 and its percent concentration;

(b) Disclose the Exposure Limit Values ACGIH TLV–TWA = 100 ppm and ACGIH TLV–STEL = 150 ppm for xylene;

(c) Disclose that a second ingredient in the controlled product has been shown to cause teratogenic effects in laboratory animals.

Registry Numbers 6509 and 6510

The claimant has been ordered to amend certain aspects of the format, content and wording of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the presence of xylene in the controlled product, its CAS Registry Number 1330-20-7 and its percent concentration;

2. Disclose that a second ingredient in the controlled product has been shown to cause teratogenic effects in laboratory animals;

3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for at least 20 minutes or until the chemical is removed;

4. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two glasses of water to drink;

5. Add oxides of nitrogen and sulphur to the list of hazardous combustion products;

6. Disclose the Exposure Limit Values ACGIH TLV–TWA = 100 ppm and ACGIH TLV–STEL = 150 ppm for xylene;

7. Registry Number 6509: Correct the implication that ethylbenzene is an ingredient of the controlled product;

8. Registry Number 6510:

(a) Disclose an LD50 (oral, rat) value of 1.26 g/kg and an LD50 (dermal, rabbit) value of 2.03 mL/kg for 2-phenoxyethanol;

(b) Disclose that both oral and dermal exposure to an ingredient in the controlled product have been shown to cause adverse effects on red blood cells in laboratory animals;

(c) Disclose that dermal exposure to an ingredient in the controlled product has been shown to cause adverse CNS effects.

Registry Numbers 6511 to 6515, inclusive

The claimant has been ordered to amend certain aspects of the format, content and wording of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the presence of xylene in the controlled product, its CAS Registry Number 1330-20-7 and its percent concentration;

2. Disclose that a second ingredient in the controlled product has been shown to cause teratogenic effects in laboratory animals;

3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for at least 20 minutes or until the chemical is removed;

4. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two glasses of water to drink;

5. Disclose the Exposure Limit Values ACGIH TLV–TWA = 100 ppm and ACGIH TLV–STEL = 150 ppm for xylene;

6. Registry Number 6512:

(a) Disclose an LD50 (oral, rat) value of 1.26 g/kg and an LD50 (dermal, rabbit) value of 2.03 mL/kg for 2-phenoxyethanol;

(b) Disclose that both oral and dermal exposure to an ingredient in the controlled product have been shown to cause adverse effects on red blood cells in laboratory animals;

(c) Disclose that dermal exposure to an ingredient in the controlled product has been shown to cause adverse CNS effects;

7. Registry Number 6513: Remove the concentration range shown for the pair of confidential hazardous ingredients disclosed under the term resin and disclose their actual concentrations or acceptable range values;

8. Registry Number 6514: Add oxides of nitrogen to the list of hazardous combustion products;

9. Registry Numbers 6511, 6512, 6513 and 6515: Add oxides of nitrogen and sulphur to the list of hazardous combustion products.

Registry Numbers 6516 and 6517

The claimant has been ordered to amend certain aspects of the format, content and wording of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for at least 20 minutes or until the chemical is removed;

2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two glasses of water to drink;

3. Add oxides of nitrogen and sulphur to the list of hazardous combustion products;

4. Disclose an LD50 (oral, rat) value of 1.26 g/kg and an LD50 (dermal, rabbit) value of 2.03 mL/kg for 2-phenoxyethanol;

5. Disclose that both oral and dermal exposure to an ingredient in the controlled product have been shown to cause adverse effects on red blood cells in laboratory animals;

6. Disclose that dermal exposure to an ingredient in the controlled product has been shown to cause adverse CNS effects;

7. Registry Number 6516:

(a) Remove the inference that the ingredient known as azo nickel complex pigment was a part of the claim for exemption;

(b) Add oxides of nitrogen and sulphur to the list of hazardous combustion products;

8. Registry Number 6517:

(a) Disclose the presence of xylene in the controlled product, its CAS Registry Number 1330-20-7 and its percent concentration;

(b) Disclose that a second ingredient in the controlled product has been shown to cause teratogenic effects in laboratory animals;

(c) Add oxides of nitrogen to the list of hazardous combustion products;

(d) Disclose the Exposure Limit Values ACGIH TLV–TWA = 100 ppm and ACGIH TLV–STEL = 150 ppm for xylene.

Registry Numbers 6518 to 6521, inclusive

The claimant has been ordered to amend certain aspects of the format, content and wording of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the presence of xylene in the controlled product, its CAS Registry Number 1330-20-7 and its percent concentration;

2. Disclose that a second ingredient in the controlled product has been shown to cause teratogenic effects in laboratory animals;

3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for at least 20 minutes or until the chemical is removed;

4. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two glasses of water to drink;

5. Add oxides of nitrogen and sulphur to the list of hazardous combustion products;

6. Disclose the Exposure Limit Values ACGIH TLV–TWA = 100 ppm and ACGIH TLV–STEL = 150 ppm for xylene;

7. Registry Numbers 6520 and 6521:

(a) Disclose an LD50 (oral, rat) value of 1.26 g/kg and an LD50 (dermal, rabbit) value of 2.03 mL/kg for 2-phenoxyethanol;

(b) Disclose that both oral and dermal exposure to an ingredient in the controlled product have been shown to cause adverse effects on red blood cells in laboratory animals;

(c) Disclose that dermal exposure to an ingredient in the controlled product has been shown to cause adverse CNS effects;

8. Registry Numbers 6518, 6519 and 6520: Disclose that a second ingredient in the controlled product has been shown to cause teratogenic effects in laboratory animals.

Registry Numbers 6522 to 6524, inclusive

The claimant has been ordered to amend certain aspects of the format, content and wording of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the presence of xylene in the controlled product, its CAS Registry Number 1330-20-7 and its percent concentration;

2. Correct the implication that ethylbenzene is an ingredient of the controlled product;

3. Disclose that a second ingredient in the controlled product has been shown to cause teratogenic effects in laboratory animals;

4. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for at least 20 minutes or until the chemical is removed;

5. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two glasses of water to drink;

6. Add oxides of nitrogen and sulphur to the list of hazardous combustion products;

7. Disclose the Exposure Limit Values ACGIH TLV–TWA = 100 ppm and ACGIH TLV–STEL = 150 ppm for xylene;

8. Registry number 6524:

(a) Disclose an LD50 (oral, rat) value of 1.26 g/kg and an LD50 (dermal, rabbit) value of 2.03 mL/kg for 2-phenoxyethanol;

(b) Disclose that both oral and dermal exposure to an ingredient in the controlled product have been shown to cause adverse effects on red blood cells in laboratory animals;

(c) Disclose that dermal exposure to an ingredient in the controlled product has been shown to cause adverse CNS effects.

Registry Number 6534

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the supplier name, mailing address and emergency telephone number of the supplier of the controlled product;

2. If the WHMIS pictograms are displayed on the MSDS, disclose the appropriate hazard symbol for a class D1 substance.

In the opinion of the screening officer, certain information should also have been shown on the label. The claimant has been ordered to amend the label as indicated below.

1. Disclose the HMIRC registry number and information relating to the progress of the claim.

Registry Number 6538

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the supplier name, mailing address and emergency telephone number of the supplier of the controlled product;

2. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed continuously with water for 30 minutes;

In the opinion of the screening officer, certain information should also have been shown on the label. The claimant has been ordered to amend the label as indicated below.

1. Disclose the HMIRC registry number and information relating to the progress of the claim.

Registry Number 6539

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Remove the inference that isopropanol and methyl alcohol were part of the claim for exemption;

2. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1A;

3. If the WHMIS pictograms are displayed on the MSDS, disclose the appropriate hazard symbol for a class D1 substance.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

In the opinion of the screening officer, certain information should also have been shown on the label. The claimant has been ordered to amend the label as indicated below.

1. Disclose the HMIRC registry number and information relating to the progress of the claim.

Registry Number 6540

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the supplier name, mailing address and emergency telephone number of the supplier of the controlled product;

2. If the WHMIS classifications are stated on the MSDS, amend the disclosure to state that the controlled product is in subdivision D1B rather than D1A;

3. If the WHMIS pictograms are displayed on the MSDS, disclose the appropriate hazard symbol for a class D1 substance.

In the opinion of the screening officer, certain information should also have been shown on the label. The claimant has been ordered to amend the label as indicated below.

1. Disclose the HMIRC registry number and information relating to the progress of the claim.

Registry Number 6542

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Delete the statement which indicates that the ingredient zinc alkyldithiophosphate is a WHMIS confidential ingredient;

2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with soap and water for at least 15 minutes.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Registry Number 6547

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Add hydrogen chloride and oxides of sulfur to the list of hazardous decomposition products.

Registry Number 6552

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the percent concentration of the hazardous ingredients in an acceptable manner;

2. Delete the statement which indicates that the ingredient proprietary component is a WHMIS confidential ingredient;

3. In relation to the first aid information shown on the MSDS for inhalation, disclose a statement to the effect that trained personnel should immediately administer cardiopulmonary resuscitation if the heart has stopped;

4. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;

5. Disclose oxides of carbon as hazardous combustion products;

6. Disclose correct information concerning the potential for polymerization of the controlled product;

7. Disclose an LD50 (oral, rat) value of 3 089 mg/kg, an LD50 (dermal, rabbit) value of 870 mg/kg and an LC50 (4 hours, vapour, mouse) value of 2 024 ppm for 2-propoxyethanol.

Registry Number 6554

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Registry Numbers 6566 and 6567

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause lesions of the nasal cavity and lung damage in laboratory animals;

2. Disclose that an ingredient in the controlled product has shown positive results in screening tests for mutagenicity;

3. Registry Number 6566: Disclose an LC50 (4 hours, rat) value of 7 093 ppm for methyl methacrylate;

4. Registry Number 6567:

(a) Disclose the presence of an additional confidential hazardous ingredient in the controlled product, together with its percent concentration;

(b) In relation to the first aid information shown on the MSDS for eye contact, disclose that flushing should continue for at least 20 minutes;

(c) Disclose oxides of carbon as hazardous combustion products.

Registry Number 6568

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause lesions of the nasal cavity and lung damage in laboratory animals;

2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for 15–30 minutes;

3. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be washed with water for 15–30 minutes;

4. Disclose that an ingredient in the controlled product has shown positive results in screening tests for mutagenicity.

Registry Number 6569

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause lesions of the nasal cavity and lung damage in laboratory animals;

2. In relation to the first aid information shown on the MSDS for eye contact, disclose that flushing should continue for at least 20 minutes;

3. Disclose oxides of carbon as hazardous combustion products;

4. Disclose that an ingredient in the controlled product has shown positive results in screening tests for mutagenicity.

Registry Number 6570

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause lesions of the nasal cavity and lung damage in laboratory animals;

2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for 15–30 minutes;

3. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be washed with water for 15–30 minutes.

Registry Numbers 6582 and 6583

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Replace the incorrect CAS No. 7711-50-0 with the correct CAS No. 77111-15-0.

Registry Number 6585

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose that acute ingestion of an ingredient in the controlled product has been shown to cause central nervous system depression in laboratory animals;

2. Disclose that absorption of an ingredient in the controlled product has been shown to cause CNS depression in laboratory animals;

3. Disclose that chronic ingestion of an ingredient in the controlled product has been shown to cause anemia and adverse effects on the brain, heart, and male reproductive organs in laboratory animals;

4. Disclose that chronic dermal exposure to an ingredient in the controlled product has been shown to cause anemia and adverse effects on the brain and heart in laboratory animals;

5. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause adverse effects on the respiratory system and male reproductive organs of laboratory animals;

6. Disclose that an ingredient in the controlled product has been shown to cause fetotoxic effects in laboratory animals at maternally toxic dose levels;

7. In relation to the first aid information for skin and eye contact already disclosed on the MSDS, add a statement to the effect that medical attention be obtained immediately;

8. Disclose oxides of carbon and nitrogen as hazardous combustion products;

9. Disclose the Exposure Limit Value ACGIH TLV–TWA = 2 mg/m3 (skin) for diethanolamine;

10. Disclose an LD50 (oral, female rat) value of 0.62 mL/kg and an LD50 (dermal, male rabbit) value of 7.46 mL/kg for diethanolamine.

Registry Number 6608

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Disclose the presence of two additional confidential hazardous ingredients in the controlled product, together with their percent concentrations;

2. In relation to the first aid information shown on the MSDS for eye contact, disclose that flushing should continue for 20 minutes;

3. Disclose that an ingredient in the controlled product has shown positive results in a screening test for mutagenicity.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Registry Number 6611

The claimant has been ordered to amend certain aspects of the format of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two glasses of water to drink. Add a statement to the effect that fluid is to be administered only under medical supervision;

2. Add oxides of nitrogen to the list of hazardous decomposition products;

3. Remove the ACGIH TLV designation from the disclosed Exposure Limit Value for particulates (not otherwise classified).

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Registry Number 6627

The claimant has been ordered to amend certain aspects of the format and wording of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Correctly identify the Exposure Limit Values for the confidential hazardous ingredient carboxylic acid ester;

2. Disclose Exposure Limit Values for another of the confidential hazardous ingredients;

3. Disclose that chronic inhalation of an ingredient in the controlled product has caused diminished vision, gastrointestinal upset and effects on the central nervous system;

4. Correctly identify the LD50 (oral, rat) value of 10 600 mg/kg as belonging to the controlled product rather than “CBI#1”;

5. Disclose an LD50 (dermal, rat) value of 16 466 mg/kg and an LC50 (4 hours, rat) value of 1 175 ppm for the controlled product;

6. Disclose that an ingredient in the controlled product has shown positive test results in an in vivo screening test for mutagenicity;

7. Disclose that ingredients in the controlled product have been shown to cause fetotoxic effects in laboratory animals.

Registry Number 6640

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the presence of an additional hazardous ingredient in the controlled product, together with its percent concentration.

Registry Number 6641

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Disclose the percent concentration of acetone in an acceptable manner;

2. Disclose the presence of an additional hazardous ingredient in the controlled product, together with its percent concentration.

Registry Number 6642

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Add hydrogen chloride to the list of hazardous decomposition products.

Registry Number 6643

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Add hydrogen chloride to the list of hazardous decomposition products.

Registry Number 6644

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Add hydrogen chloride and oxides of sulphur to the list of hazardous decomposition products.

Registry Number 6645

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Add hydrogen chloride to the list of hazardous decomposition products.

Registry Number 6654

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the ceiling Exposure Limit Value of 100 ppm for the confidential hazardous ingredient alcohol 1;

2. Disclose the lower LD50 (oral, rat) value of 4 000 mg/kg for the confidential hazardous ingredient alcohol 1;

3. Disclose that chronic ingestion of an ingredient in the controlled product has been shown to cause liver and kidney damage in laboratory animals;

4. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause adverse kidney effects in laboratory animals.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Registry Number 6667

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for at least 20 minutes or until the chemical is removed;

2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two glasses of water to drink;

3. Disclose oxides of carbon, sulphur and nitrogen as hazardous combustion products.

Registry Number 6676

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Clarify that the ACGIH TWA Exposure Limit Value of 100 ppm shown on the MSDS for the hazardous ingredient n-amyl acetate is actually a “STEL” value and further disclose the Exposure Limit Value ACGIH TLV–TWA = 50 ppm for the same ingredient;

2. Disclose the lower Exposure Limit Value ACGIH TLV–TWA = 20 ppm for toluene;

3. Disclose the lower Exposure Limit Value ACGIH TLV–STEL = 150 ppm for xylene;

4. Disclose the Exposure Limit Value ACGIH TLV–STEL = 250 ppm (skin) for methanol and add the skin notation to the ACGIH TLV–TWA value as well;

5. Disclose the Exposure Limit Value AIHA WEEL (TWA, 8 hours) = 50 ppm for propylene glycol monomethyl ether acetate;

6. Correct the implication that ethylbenzene is an ingredient of the controlled product;

7. Disclose that acute dermal exposure to an ingredient in the controlled product has caused skin corrosion and renal failure;

8. Disclose that acute inhalation of ingredients in the controlled product has caused CNS effects;

9. Disclose that chronic inhalation of an ingredient in the controlled product has caused colour vision loss in humans and has been shown to cause hearing loss in laboratory animals;

10. Disclose that chronic inhalation of a second ingredient in the controlled product has been shown to cause hearing loss in laboratory animals;

11. Disclose that ingestion of an ingredient in the controlled product has been shown to cause fetotoxic effects in laboratory animals;

12. Revise the MSDS to show that formaldehyde has been classified as a suspected human carcinogen (A2) by the American Conference of Governmental Industrial Hygienists (ACGIH);

13. In relation to the first aid information shown on the MSDS for ingestion, indicate that vomiting should not be induced;

14. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for at least 30 minutes. Also disclose that contaminated clothing, including contaminated footwear and leather goods, should be removed under running water;

15. Disclose an LD50 (oral, rat) value of 10 060 mg/kg and an LC50 (4 hours, rat) value of 31 600 ppm for ethanol;

16. Disclose an LD50 (oral, rat) value of 2.51 g/kg for n-butyl alcohol;

17. Disclose an LD50 (oral, rat) value of 7 000 mg/kg for n-amyl acetate;

18. Disclose an LD50 (oral, rat) value of 2 900 mg/kg for phenol-formaldehyde resin;

19. Disclose an LD50 (oral, rat) value of 13.0 mL/kg and an LD50 (dermal, rabbit) value of 15 800 mg/kg for methanol;

20. Disclose an LD50 (oral, rat) value of 530 mg/kg for phenol;

21. Disclose an LD50 (oral, rat) value of 3 523 mg/kg and an LC50 (4 hours, rat) value of 6 350 ppm for xylene;

22. Disclose an LD50 (dermal, rabbit) value of 14.1 mL/kg and an LC50 (4 hours, female rat) value of 5 100 ppm for toluene;

23. Disclose that an ingredient in the controlled product is considered to be a germ cell mutagen based on positive results in in vivo screening tests and that it has been shown to cause mutagenic effects in human cells, in vitro;

24. Disclose that another ingredient in the controlled product has shown positive test results in in vitro screening tests for mutagenicity;

25. Disclose that acetylsalicylic acid and hexane synergistically enhance the hearing loss caused by inhalation exposure to toluene in laboratory animals.

Registry Number 6678

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Clarify that the ACGIH TWA Exposure Limit Value of 100 ppm shown on the MSDS for the hazardous ingredient n-amyl acetate is actually a “STEL” value and further disclose the Exposure Limit Value ACGIH TLV–TWA = 50 ppm for the same ingredient;

2. Disclose the lower Exposure Limit Value ACGIH TLV–TWA = 20 ppm for toluene;

3. Disclose the lower Exposure Limit Value ACGIH TLV–STEL = 150 ppm for xylene;

4. Disclose the Exposure Limit Value ACGIH TLV–STEL = 250 ppm (skin) for methanol and add the skin notation to the ACGIH TLV–TWA value as well;

5. Disclose the Exposure Limit Value AIHA WEEL (TWA, 8 hours) = 50 ppm for propylene glycol monomethyl ether acetate;

6. Disclose the Exposure Limit Value ACGIH TLV–STEL = 250 ppm for n-propyl acetate;

7. Disclose the Exposure Limit Value ACGIH TLV–STEL = 200 ppm for n-butyl acetate;

8. Correct the implication that ethylbenzene is an ingredient of the controlled product;

9. Disclose that acute dermal exposure to an ingredient in the controlled product has caused skin corrosion and renal failure;

10. Disclose that acute inhalation of ingredients in the controlled product has caused CNS effects;

11. Disclose that chronic inhalation of an ingredient in the controlled product has caused colour vision loss in humans and has been shown to cause hearing loss in laboratory animals;

12. Disclose that chronic inhalation of a second ingredient in the controlled product has been shown to cause hearing loss in laboratory animals;

13. In relation to the first aid information shown on the MSDS for ingestion, indicate that vomiting should not be induced;

14. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for at least 30 minutes. Also disclose that contaminated clothing, including contaminated footwear and leather goods, should be removed under running water;

15. Disclose an LD50 (oral, rat) value of 9.8 mL/kg for n-propyl acetate;

16. Disclose an LD50 (oral, rat) value of 10 060 mg/kg and an LC50 (4 hours, rat) value of 31 600 ppm for ethanol;

17. Disclose an LD50 (oral, rat) value of 2.51 g/kg for n-butyl alcohol;

18. Disclose an LD50 (oral, rat) value of 7 000 mg/kg for n-amyl acetate;

19. Disclose an LD50 (oral, rat) value of 2 900 mg/kg for phenol-formaldehyde resin;

20. Disclose an LD50 (oral, rat) value of 13.0 mL/kg and an LD50 (dermal, rabbit) value of 15 800 mg/kg for methanol;

21. Disclose an LD50 (oral, rat) value of 3 523 mg/kg and an LC50 (4 hours, rat) value of 6 350 ppm for xylene;

22. Disclose an LD50 (dermal, rabbit) value of 14.1 mL/kg and an LC50 (4 hours, female rat) value of 5 100 ppm for toluene;

23. Disclose an LC50 (4 hours, aerosol, rat) value of 160 ppm for n-butyl acetate;

24. Disclose that an ingredient in the controlled product is considered to be a germ cell mutagen based on positive results in in vivo screening tests and that it has been shown to cause mutagenic effects in human cells, in vitro;

25. Disclose that a second ingredient in the controlled product has shown positive results in in vivo screening tests for mutagenicity;

26. Disclose that an ingredient in the controlled product is considered to be a fetotoxin and that another ingredient has been shown to be a fetotoxin (by inhalation), in tests on laboratory animals;

27. Revise the MSDS to show that formaldehyde has been classified as a suspected human carcinogen (A2) by the American Conference of Governmental Industrial Hygienists (ACGIH);

28. Disclose that acetylsalicylic acid and hexane synergistically enhance the hearing loss caused by inhalation exposure to toluene in laboratory animals.

Registry Number 6680

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the lower Exposure Limit Value ACGIH TLV–TWA = 20 ppm for toluene;

2. Correct the implication that ethylbenzene is an ingredient of the controlled product;

3. Disclose that chronic exposure to xylene vapours has caused skin sensitization in a worker;

4. Disclose that acute ingestion of an ingredient of the controlled product has been shown to cause adverse CNS effects and gastrointestinal tract disturbances;

5. Disclose that chronic inhalation of an ingredient in the controlled product has caused colour vision loss in humans and has been shown to cause hearing loss in laboratory animals;

6. Disclose that an ingredient in the controlled product has been shown to cause fetotoxic effects in laboratory animals in the absence of maternal toxic effects and that another ingredient in the controlled product has been shown to cause fetotoxic effects in laboratory animals at maternally toxic dose levels;

7. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be flushed for at least 20 minutes and that medical attention should be obtained immediately;

8. Disclose an LD50 (oral, rat) value of 2.51 g/kg for n-butyl alcohol;

9. Disclose an LD50 (oral, rat) value of 9.8 mL/kg for n-propyl acetate;

10. Disclose an LD50 (oral, rat) value of 3 523 mg/kg and an LC50 (4 hours, rat) value of 6 350 ppm for xylene;

11. Disclose an LD50 (dermal, rabbit) value of 12 800 mg/kg and an LC50 (8 hours, rat) value of 12 000 ppm for isopropanol;

12. Disclose an LD50 (dermal, rabbit) value of 14.1 mL/kg for toluene;

13. Disclose that acetylsalicylic acid synergistically enhances the hearing loss caused by inhalation exposure to toluene in laboratory animals.

Registry Number 6682

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Add oxides of sulfur to the list of hazardous decomposition or combustion products;

2. Disclose the LD50 (oral, rat) value of 1 410 mg/kg for the confidential hazardous ingredient proprietary aromatic acid.

Registry Number 6683

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose an LD50 (oral, rat) value of 1 020 mg/kg, an LD50 (dermal, rabbit) value of 560 mg/kg and an LC50 (4 hours, aerosol, rat) value of 3 070 mg/m3 for N-vinyl-2-pyrollidone.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Registry Numbers 6685 and 6686

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS.

Registry Number 6689

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the percent concentration of the hazardous ingredients in an acceptable manner;

2. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed continuously with water for at least 30 minutes;

3. Disclose oxides of carbon as hazardous combustion products;

4. Disclose the Exposure Limit Value AIHA WEEL = 10 ppm for benzyl alcohol;

5. Disclose correct information concerning the potential for polymerization of the controlled product;

6. Disclose an LD50 (oral, rat) value of 1 230 mg/kg and an LD50 (dermal, rabbit) value of 2 000 mg/kg for benzyl alcohol;

7. Disclose an LD50 (oral, rat) value of 1 030 mg/kg for isophoronediamine;

8. Disclose that an ingredient in the controlled product has been shown to be corrosive to the eyes of laboratory animals;

9. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in mammalian cells in vitro.

Registry Number 6699

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Delete the statement which indicates that the ingredient proprietary component is a WHMIS confidential ingredient;

2. In relation to the first aid information shown on the MSDS for inhalation, disclose a statement to the effect that trained personnel should immediately administer cardiopulmonary resuscitation if the heart has stopped;

3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;

4. Disclose oxides of carbon as hazardous combustion products;

5. Disclose an LD50 (oral, rat) value of 3 089 mg/kg, an LD50 (dermal, rabbit) value of 870 mg/kg and an LC50 (4 hours, vapour, mouse) value of 2 024 ppm for 2-propoxyethanol.

Registry Number 6700

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Registry Number 6711

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose an LD50 (oral, rat) value of 3 200 mg/kg for solvent naphtha (petroleum) heavy arom;

2. Disclose that an ingredient in the controlled product has been shown to cause fetotoxic effects in laboratory animals at maternally toxic dose levels.

Registry Numbers 6712 and 6713

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose that an ingredient in the controlled product has been shown to cause adverse reproductive effects in laboratory animals;

2. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in classes D1A and D2A.

Registry Number 6714

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS.

Registry Number 6719

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed continuously with water for at least 30 minutes;

2. Disclose oxides of carbon as hazardous combustion products;

3. Disclose correct information concerning the potential for polymerization of the controlled product.

Registry Number 6725

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two glasses of water to drink.

Registry Number 6726

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Disclose the presence of an additional confidential hazardous ingredient in the controlled product, together with its percent concentration;

2. Remove the inference that the ingredient known as alkylamine was a part of the claim for exemption;

3. Disclose LC50 values for one of the confidential hazardous ingredients in an acceptable manner;

4. Disclose that ingestion of an ingredient in the controlled product has caused methemoglobinemia;

5. Disclose that subchronic ingestion of an ingredient in the controlled product has been shown to cause adverse effects on sperm production in laboratory animals;

6. Disclose that an ingredient in the controlled product has shown positive results in a screening test for mutagenicity.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Registry Number 6727

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the percent concentrations of N,N-diethyl-p-phenylene-diamine sulfate and organic acid in an acceptable manner;

2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give diluted milk of magnesia to drink;

3. In relation to the first aid information shown on the MSDS for ingestion, modify or remove the statement to give water to drink.

Registry Number 6732

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS.

Registry Number 6733

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose that acute oral exposure to an ingredient in the controlled product has caused temporary visual disturbances and adverse heart effects in humans and has also been shown to cause bladder and immunological effects in laboratory animals;

2. Disclose that chronic inhalation of an ingredient in the controlled product has caused colour vision loss;

3. Disclose the lower Exposure Limit Value ACGIH TLV–TWA = 20 ppm for toluene;

4. Disclose that acetylsalicylic acid and hexane synergistically enhance the hearing loss caused by inhalation exposure to toluene in laboratory animals.

Registry Number 6734

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the lower LD50 (oral, rat) value of 3 000 mg/kg for
o
-xylene;

2. Disclose an LD50 (oral, rat) value of 3 200 mg/kg for solvent naphtha (petroleum) heavy arom;

3. Disclose that ingestion of an ingredient in the controlled product has caused CNS effects.

Registry Numbers 6744 and 6745

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS.

Registry Number 6816

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in bacterial cells in vitro;

2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give large amounts of water to drink;

3. In relation to the first aid information shown on the MSDS for inhalation, disclose a statement to the effect that trained personnel should immediately administer cardiopulmonary resuscitation if the heart has stopped;

4. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;

5. Disclose oxides of carbon as hazardous combustion products;

6. Disclose an LD50 (dermal, rabbit) value of 400 mg/kg and an LC50 (4 hours, rat) value of 450 ppm for ethylene glycol monobutyl ether;

7. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1A.

Registry Number 6819

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose an LD50 (oral, rat) value of 1 022 mg/kg, an LD50 (dermal, rabbit) value of 560 mg/kg and an LC50 (4 hours, aerosol, rat) value of 3 070 mg/m3 for N-vinyl-2-pyrollidone.

Registry Number 6822

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the Province of Alberta 15 minute occupational exposure limit value of 3 mg/m3 for sulphuric acid;

2. Disclose information pertaining to acute lethality via dermal exposure for one of the confidential hazardous ingredients;

3. Disclose that acute ingestion of an ingredient in the controlled product has been shown to cause liver damage in laboratory animals;

4. In relation to the period of time shown on the MSDS for flushing the skin with water should skin contact occur, delete the current time frame and replace it with a time of “at least thirty minutes”;

5. In relation to the period of time shown on the MSDS for flushing the eyes with water should eye contact occur, delete the current time frame and replace it with a time of “at least thirty minutes”;

6. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give water to drink.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Registry Number 6881

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for skin contact, disclose that medical attention should be obtained.

Registry Number 6882

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for skin contact, disclose that medical attention should be obtained;

2. Indicate that the flash point is 45°C.

Registry Number 6901

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose that an ingredient in the controlled product has caused potentiating effects with chloroform.

Registry Number 6908

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Disclose the percent concentration of certain of the hazardous ingredients in an acceptable manner;

2. Remove the concentration ranges shown for the ingredients poly(aromatic glycidyl ether) and acetone and disclose their actual concentrations or acceptable range values;

3. Disclose the presence of an additional hazardous ingredient in the controlled product, together with its CAS registry number and percent concentration;

4. Add oxides of sulphur and chlorine to the list of hazardous combustion products.

Registry Number 6912

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Disclose the percent concentration of certain of the hazardous ingredients in an acceptable manner;

2. Disclose the presence of titanium dioxide in the controlled product, its CAS Registry Number 13463-67-7 and its percent concentration;

3. Disclose that an ingredient in the controlled product has been classified as possibly carcinogenic to humans (Group 2B) by the International Agency for Research on Cancer (IARC);

4. Disclose the Exposure Limit Value ACGIH TLV–TWA = 10 mg/m3 for titanium dioxide;

5. Add oxides of chlorine to the list of hazardous combustion products.

Registry Number 6914

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Add oxides of chlorine to the list of hazardous combustion products.

Registry Number 6923

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Delete the statement which indicates that the ingredient zinc alkyldithiophosphate is a WHMIS confidential ingredient;

2. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed with water for at least 15 minutes;

3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with soap and water for at least 15 minutes;

4. Add oxides of nitrogen to the list of hazardous thermal decomposition products;

5. Remove the statement that the controlled product does not meet the criteria for a classification of D2B as an eye irritant.

Registry Number 6949

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Disclose a lower LD50 (oral, rat) value of 272 mg/kg and a lower LC50 (4 hours, rat, vapour) value of 890 ppm for the confidential hazardous ingredient alkyl amine.

Registry Numbers 7031 and 7032

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with soap and water for 20 minutes.

Registry Number 7080

The claimant has been ordered to amend certain aspects of the wording of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for inhalation, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;

2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;

3. In relation to the period of time shown on the MSDS for flushing the eyes with water should eye contact occur, delete the current reference to “ten minutes” and replace it with a time of “at least fifteen minutes”;

4. Add carbon dioxide to the list of hazardous combustion products.

Registry Numbers 7101 to 7103, inclusive

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the percent concentration of sodium hydrosulfite in an acceptable manner;

2. Remove the statements implying that the controlled product is corrosive;

3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that contaminated clothing, shoes and leather goods should be removed under running water.

Registry Numbers 7104 to 7106, inclusive

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS.

Having regard to the foregoing, and pursuant to section 17 of the Hazardous Materials Information Review Act, notice is hereby given that the screening officer has, for each of the above-noted claims, with the exceptions of those claims bearing Registry Numbers 6231, 6410, 6411, 6487, 6492, 6493, 6534, 6538, 6539, 6540, 6566, 6567, 6568, 6569, 6570, 6586, 6594, 6724 and 6766, directed the claimant to comply with the provisions of the Hazardous Products Act and the Controlled Products Regulations within 30 days from the expiry of the appeal period, except that the information in respect of which the claim for exemption was made does not have to be disclosed, and to provide a copy of the amended MSDS to the screening officer within 40 days of expiry of the appeal period.

In the cases of the claims bearing Registry Numbers 6231, 6566, 6567, 6568, 6569 and 6570, the screening officer has directed the claimants to comply with the provisions of the Occupational Health and Safety Act of the Province of Ontario, except that the information in respect of which the claims for exemption were made does not have to be disclosed, and to provide a copy of the amended MSDS and, in the case of the claim bearing Registry Number 6231, the amended label to the screening officer within the respective time period specified in the foregoing paragraph.

In the cases of the claims bearing Registry Numbers 6411, 6487, 6534, 6538, 6539 and 6540, the screening officer has directed the claimants to comply with the provisions of the Occupational Health and Safety Code 2006 of the Province of Alberta, except that the information in respect of which the claims for exemption were made does not have to be disclosed, and to provide a copy of the amended MSDS and, in the cases of the claims bearing Registry Numbers 6411, 6534, 6538, 6539 and 6540, the amended label to the screening officer, within the respective time period specified in a foregoing paragraph.

Pursuant to paragraph 18(1)(b) of the Hazardous Materials Information Review Act, this notice includes certain information which, in the opinion of the screening officer, should have been shown on the relevant MSDS.

Pursuant to subsection 24(1) of the Controlled Products Regulations, amended MSDSs must be available in both official languages.

Section 20 of the Hazardous Materials Information Review Act affords the opportunity to a claimant or any affected party, within the meaning of subsection 2(2) of the Hazardous Materials Information Review Regulations, to appeal a decision or order of a screening officer. To initiate the appeal process, a Statement of Appeal (Form 1) as prescribed by the Hazardous Materials Information Review Act Appeal Board Procedures Regulations must be completed and delivered within 45 days of the publication of this notice in the Canada Gazette, Part I, to the acting Chief Appeals Officer at the following address: Hazardous Materials Information Review Commission, 427 Laurier Avenue W, 7th Floor, Ottawa, Ontario K1A 1M3, 613-941-2945.

R. BOARDMAN
Chief Screening Officer

[27-1-o]